File name,Patient ID,COVID Positive?,Location,Age,Gender,Medical history,Time,Severity,Other diseases,DOI,Captions
2020.03.18.20038125-p16-56-6.png,Patient 144,1,"""Diamond Princess"" Cruise Ship",75,M,an increase of extent of GGO with crazy-paving appearance, On the tenth day of admission,severe,,,"['Figure 2. The progress of CT findings in a patient with COVID-19. On the tenth day of admission, a follow-up chest CT scan showed an increase of extent of GGO with crazy-paving appearance (D, E and F).']"
2020.03.18.20038125-p16-56-5.png,Patient 144,1,"""Diamond Princess"" Cruise Ship",75,M,an increase of extent of GGO with crazy-paving appearance, On the tenth day of admission,severe,,,"['Figure 2. The progress of CT findings in a patient with COVID-19. On the tenth day of admission, a follow-up chest CT scan showed an increase of extent of GGO with crazy-paving appearance (D, E and F).']"
2020.03.18.20038125-p16-56-4.png,Patient 144,1,"""Diamond Princess"" Cruise Ship",75,M,an increase of extent of GGO with crazy-paving appearance, On the tenth day of admission,severe,,,"['Figure 2. The progress of CT findings in a patient with COVID-19. On the tenth day of admission, a follow-up chest CT scan showed an increase of extent of GGO with crazy-paving appearance (D, E and F).']"
2020.03.18.20038125-p16-56-3.png,Patient 144,1,"""Diamond Princess"" Cruise Ship",75,M,"On the fourth day of admission, he showed tachypnea and hypoxemia", On the day of admission,severe,,,"['Figure 2. The progress of CT findings in a patient with COVID-19. A male patient 75 years old was asymptomatic on the admission day. On the fourth day of admission, he showed tachypnea and hypoxemia, and treated oxygen therapy. On the admission day, Chest CT scan showed multifocal GGO adjacent to the parietal pleura in multiple lobes with emphysematous changes (A, B and C).']"
2020.03.18.20038125-p16-56-2.png,Patient 144,1,"""Diamond Princess"" Cruise Ship",75,M,"On the fourth day of admission, he showed tachypnea and hypoxemia", On the day of admission,severe,,,"['Figure 2. The progress of CT findings in a patient with COVID-19. A male patient 75 years old was asymptomatic on the admission day. On the fourth day of admission, he showed tachypnea and hypoxemia, and treated oxygen therapy. On the admission day, Chest CT scan showed multifocal GGO adjacent to the parietal pleura in multiple lobes with emphysematous changes (A, B and C).']"
2020.03.18.20038125-p16-56-1.png,Patient 144,1,"""Diamond Princess"" Cruise Ship",75,M,"On the fourth day of admission, he showed tachypnea and hypoxemia", On the day of admission,severe,,,"['Figure 2. The progress of CT findings in a patient with COVID-19. A male patient 75 years old was asymptomatic on the admission day. On the fourth day of admission, he showed tachypnea and hypoxemia, and treated oxygen therapy. On the admission day, Chest CT scan showed multifocal GGO adjacent to the parietal pleura in multiple lobes with emphysematous changes (A, B and C).']"
2020.03.18.20038125-p15-54-6.png,Patient 143,1,"""Diamond Princess"" Cruise Ship",76,M,"the GGO with consolidation, bronchial wall thickening, and bronchiectasis in the left lower lobe",,asymptomatic ,,,"['Figure 1. The CT pattern of abnormal lung findings among asymptomatic patients with COVID-19. A patient 76 years old, male. CT scan showed the GGO with consolidation, bronchial wall thickening, and bronchiectasis in the left lower lobe (F).']"
2020.03.18.20038125-p15-54-5.png,Patient 143,1,"""Diamond Princess"" Cruise Ship",70,F,The GGO with interlobular septal thickening (crazy-paving appearance) adjacent to the parietal pleura in the both lower lobes,,asymptomatic ,,,"['Figure 1. The CT pattern of abnormal lung findings among asymptomatic patients with COVID-19. A patient 70 years old, female. The GGO with interlobular septal thickening (crazy-paving appearance) adjacent to the parietal pleura in the both lower lobes (E).']"
2020.03.18.20038125-p15-54-4.png,Patient 143,1,"""Diamond Princess"" Cruise Ship",73,F, The patchy non-segmental ground grass opacity (GGO) adjacent to the parietal pleura in the right upper lobe,,asymptomatic ,,,"['Figure 1. The CT pattern of abnormal lung findings among asymptomatic patients with COVID-19. A patient 73 years old, female. The patchy non-segmental ground grass opacity (GGO) adjacent to the parietal pleura in the right upper lobe (A and B), and in both lower lobes (C and D). ']"
2020.03.18.20038125-p15-54-2.png,Patient 143,1,"""Diamond Princess"" Cruise Ship",73,F, The patchy non-segmental ground grass opacity (GGO) adjacent to the parietal pleura in the right upper lobe,,asymptomatic ,,,"['Figure 1. The CT pattern of abnormal lung findings among asymptomatic patients with COVID-19. A patient 73 years old, female. The patchy non-segmental ground grass opacity (GGO) adjacent to the parietal pleura in the right upper lobe (A and B), and in both lower lobes (C and D). ']"
2020.02.25.20027763-p15-53%1.png,Patient 57,1,"Beijing, China",N/A,N/A,,have fever and cough,mild,,10.1101/2020.02.25.20027763,"['Figure 2. CT findings in 4 patients with confirmed COVID-19. B. A round-like, mixed GGO and consolidation lesion (with reversed halo sign) in subpleural area in right lower lung.']"
2020.02.25.20027763-p15-53%0.png,Patient 56,1,"Beijing, China",N/A,N/A,,have fever for more than 3 days,mild,,10.1101/2020.02.25.20027763,['Figure 2. CT findings in 4 patients with confirmed COVID-19. A. Patchy GGO distributed in subpleural area in left lower lung.']
2020.02.24.20027052-p8-73%3.png,Patient 27,1,"Beijing, China",44,M,,,critical,,,"['Figure 4. Quantification of EAT density by CT scan. CT scan examples of the patients from light (a), mild (b), severe (c) and critical (d) group of COVID-19 patients. Dark red areas represent the EATs, and blue areas indicate other heart tissues. Red arrows indicate lung lesions, and ground-glass opacity features are obviously presented in severe (c) and critical (d) groups (marked with red arrow). Scale bar, 10 cm. ']"
2020.02.24.20027052-p8-73%2.png,Patient 26,1,"Beijing, China",65,M,,,severe,,,"['Figure 4. Quantification of EAT density by CT scan. CT scan examples of the patients from light (a), mild (b), severe (c) and critical (d) group of COVID-19 patients. Dark red areas represent the EATs, and blue areas indicate other heart tissues. Red arrows indicate lung lesions, and ground-glass opacity features are obviously presented in severe (c) and critical (d) groups (marked with red arrow). Scale bar, 10 cm. ']"
2020.02.24.20027052-p8-73%1.png,Patient 25,1,"Beijing, China",37,M,,,mild,,,"['Figure 4. Quantification of EAT density by CT scan. CT scan examples of the patients from light (a), mild (b), severe (c) and critical (d) group of COVID-19 patients. Dark red areas represent the EATs, and blue areas indicate other heart tissues. Red arrows indicate lung lesions, and ground-glass opacity features are obviously presented in severe (c) and critical (d) groups (marked with red arrow). Scale bar, 10 cm. ']"
2020.02.24.20027052-p8-73%0.png,Patient 24,1,"Beijing, China",44,F,,,light,,,"['Figure 4. Quantification of EAT density by CT scan. CT scan examples of the patients from light (a), mild (b), severe (c) and critical (d) group of COVID-19 patients. Dark red areas represent the EATs, and blue areas indicate other heart tissues. Red arrows indicate lung lesions, and ground-glass opacity features are obviously presented in severe (c) and critical (d) groups (marked with red arrow). Scale bar, 10 cm. ']"
2020.02.10.20021584-p6-52%9.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 15, Hospital Day 7",Absorption stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (C) Ground glass shadow absorption and reduced consolidation area (Illness Day 15, Hospital Day 7).']"
2020.02.10.20021584-p6-52%8.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 15, Hospital Day 7",Absorption stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (C) Ground glass shadow absorption and reduced consolidation area (Illness Day 15, Hospital Day 7).']"
2020.02.10.20021584-p6-52%7.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 11, Hospital Day 3 ",Consolidation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (B) Ground glass shadow expanding and consolidation in bilateral lung (Illness Day 11, Hospital Day 3). ']"
2020.02.10.20021584-p6-52%6.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 11, Hospital Day 3 ",Consolidation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (B) Ground glass shadow expanding and consolidation in bilateral lung (Illness Day 11, Hospital Day 3). ']"
2020.02.10.20021584-p6-52%5.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 11, Hospital Day 3 ",Consolidation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (B) Ground glass shadow expanding and consolidation in bilateral lung (Illness Day 11, Hospital Day 3). ']"
2020.02.10.20021584-p6-52%4.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 11, Hospital Day 3 ",Consolidation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (B) Ground glass shadow expanding and consolidation in bilateral lung (Illness Day 11, Hospital Day 3). ']"
2020.02.10.20021584-p6-52%3.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 8, Hospital Day 0 ",Early stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (A) Ground glass shadow in multiple lobes and segments of bilateral lungs, and the lesions were adjacent to the pleura (Illness Day 8, Hospital Day 0). ']"
2020.02.10.20021584-p6-52%2.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 8, Hospital Day 0 ",Early stage ,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (A) Ground glass shadow in multiple lobes and segments of bilateral lungs, and the lesions were adjacent to the pleura (Illness Day 8, Hospital Day 0). ']"
2020.02.10.20021584-p6-52%15.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 20, Hospital Day 12",Dissipation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (D) Lesion dissipation (Illness Day 20, Hospital Day 12). ']"
2020.02.10.20021584-p6-52%14.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 20, Hospital Day 12",Dissipation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (D) Lesion dissipation (Illness Day 20, Hospital Day 12). ']"
2020.02.10.20021584-p6-52%13.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 20, Hospital Day 12",Dissipation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (D) Lesion dissipation (Illness Day 20, Hospital Day 12). ']"
2020.02.10.20021584-p6-52%12.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 20, Hospital Day 12",Dissipation stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (D) Lesion dissipation (Illness Day 20, Hospital Day 12). ']"
2020.02.10.20021584-p6-52%11.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 15, Hospital Day 7",Absorption stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (C) Ground glass shadow absorption and reduced consolidation area (Illness Day 15, Hospital Day 7).']"
2020.02.10.20021584-p6-52%10.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 15, Hospital Day 7",Absorption stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (C) Ground glass shadow absorption and reduced consolidation area (Illness Day 15, Hospital Day 7).']"
2020.02.10.20021584-p6-52%1.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 8, Hospital Day 0 ",Early stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (A) Ground glass shadow in multiple lobes and segments of bilateral lungs, and the lesions were adjacent to the pleura (Illness Day 8, Hospital Day 0). ']"
2020.02.10.20021584-p6-52%0.png,Patient 2,1,"Beijing, China",50,M,,"Illness Day 8, Hospital Day 0 ",Early stage,,,"['Figure 1. A 50-year-old man with 2019 novel coronavirus (2019-nCoV) infection. (A) Ground glass shadow in multiple lobes and segments of bilateral lungs, and the lesions were adjacent to the pleura (Illness Day 8, Hospital Day 0). ']"
2020.03.04.20031047-p14-87%1.png,Patient 105,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 3, CT imaging of a patient with both heart failure and COVID-19. B, Big patchy GGO with irregular morphology in bilateral lungs. Peribronchovascular thickening and subpleural effusion were also found. ']"
2020.03.04.20031047-p14-87%0.png,Patient 105,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 3, CT imaging of a patient with both heart failure and COVID-19. A, Diffuse disease mixed with GGO and consolidation in bilateral upper lungs, accompanied with interlobular septal thickening and subpleural effusion.']"
2020.03.04.20031047-p13-84%5.png,Patient 104,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 2, Different imaging features for heart failure and COVID-19. F, Patchy lesion of Crazy Paving Pattern in left upper lung with partial consolidation inside.']"
2020.03.04.20031047-p13-84%4.png,Patient 103,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 2, Different imaging features for heart failure and COVID-19. E, Multiple disease mixed with GGO and consolidation in bilateral lungs.  Fibrous lesion (arrow) was found in the left lung.']"
2020.03.04.20031047-p13-84%3.png,Patient 102,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 2, Different imaging features for heart failure and COVID-19. D, Big patchy GGO in left lung. Interlobular septal thickening was also found inside.']"
2020.03.04.20031047-p13-84%2.png,Patient 101,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 2, Different imaging features for heart failure and COVID-19. C, Patchy lesion of Crazy Paving Pattern in right upper lung with partial consolidation inside. Small pulmonary vein enlargement (arrow) was also found, accompanied with subpleural effusion in the right lung. ']"
2020.03.04.20031047-p13-84%1.png,Patient 100,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 2, Different imaging features for heart failure and COVID-19. B, Subpleural GGO with band-shaped morphology (arrow) in the dorsal segment of bilateral lungs. Interlobular septal thickening and cardiac enlargement were also found.']"
2020.03.04.20031047-p13-84%0.png,Patient 99,1,"Changsha, China.",N/A,N/A,,,severe,,10.1101/2020.03.04.20031047,"['FIGURE 2, Different imaging features for heart failure and COVID-19. A, Big patchy GGO in left lung and sporadic GGO in right lung. Peribronchovascular thickening, fissural thickening (arrow) were also found with subpleural effusion.']"
2020.03.13.20035212-p23-163.png,Patient 139,1,China (Unspecified Region),N/A,N/A,,day 17 after symptom onset,severe,,10.1101/2020.03.13.20035212,"['Figure 4. The course of chest CT images of case 8. (D) Images from February 11 show the further enlarged ground-glass opacity of the left upper lung. New ground-glass opacity is visible in the rest areas of lungs. The left pleural effusion decreased, and the right pleural effusion increased.']"
2020.03.13.20035212-p23-162.png,Patient 138,1,China (Unspecified Region),N/A,N/A,,day 17 after symptom onset,severe,,10.1101/2020.03.13.20035212,"['Figure 4. The course of chest CT images of case 8. (D) Images from February 11 show the further enlarged ground-glass opacity of the left upper lung. New ground-glass opacity is visible in the rest areas of lungs. The left pleural effusion decreased, and the right pleural effusion increased.']"
2020.03.13.20035212-p23-161.png,Patient 137,1,China (Unspecified Region),N/A,N/A,,day 17 after symptom onset,severe,,10.1101/2020.03.13.20035212,"['Figure 4. The course of chest CT images of case 8. (D) Images from February 11 show the further enlarged ground-glass opacity of the left upper lung. New ground-glass opacity is visible in the rest areas of lungs. The left pleural effusion decreased, and the right pleural effusion increased.']"
2020.03.13.20035212-p23-160.png,Patient 136,1,China (Unspecified Region),N/A,N/A,,day 13 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (C) Images from February 7 show increased ground-glass opacity of the left upper lung with bilateral pleural effusion. A small area of new ground-glass opacity appeared in the right lung.']
2020.03.13.20035212-p23-159.png,Patient 135,1,China (Unspecified Region),N/A,N/A,,day 13 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (C) Images from February 7 show increased ground-glass opacity of the left upper lung with bilateral pleural effusion. A small area of new ground-glass opacity appeared in the right lung.']
2020.03.13.20035212-p23-158.png,Patient 134,1,China (Unspecified Region),N/A,N/A,,day 13 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (C) Images from February 7 show increased ground-glass opacity of the left upper lung with bilateral pleural effusion. A small area of new ground-glass opacity appeared in the right lung.']
2020.03.13.20035212-p23-157.png,Patient 133,1,China (Unspecified Region),N/A,N/A,,day 9 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (B) Images from February 3 show bilateral pleural effusion and pericardial effusion with a small area of ground-glass opacity in the left upper lung.']
2020.03.13.20035212-p23-156.png,Patient 132,1,China (Unspecified Region),N/A,N/A,,day 9 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (B) Images from February 3 show bilateral pleural effusion and pericardial effusion with a small area of ground-glass opacity in the left upper lung.']
2020.03.13.20035212-p23-155.png,Patient 131,1,China (Unspecified Region),N/A,N/A,,day 9 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (B) Images from February 3 show bilateral pleural effusion and pericardial effusion with a small area of ground-glass opacity in the left upper lung.']
2020.03.13.20035212-p23-154.png,Patient 130,1,China (Unspecified Region),N/A,N/A,,day 1 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (A) Images from January 26 show bilateral pleural effusion and pericardial effusion.']
2020.03.13.20035212-p23-153.png,Patient 129,1,China (Unspecified Region),N/A,N/A,,day 1 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (A) Images from January 26 show bilateral pleural effusion and pericardial effusion.']
2020.03.13.20035212-p23-152.png,Patient 128,1,China (Unspecified Region),N/A,N/A,,day 1 after symptom onset,severe,,10.1101/2020.03.13.20035212,['Figure 4. The course of chest CT images of case 8. (A) Images from January 26 show bilateral pleural effusion and pericardial effusion.']
2020.03.12.20034686-p17-91-6.png,Patient 127,1,China (Unspecified Region),1,N/A,,day 11-12 after treatment,mild,,10.1101/2020.03.12.20034686,['Fig 2. Typical Features of CT Images of Paediatric Patients with COVID-19.']
2020.03.12.20034686-p17-91-5.png,Patient 126,1,China (Unspecified Region),1,N/A,,day 11-12 after treatment,mild,,10.1101/2020.03.12.20034686,['Fig 2. Typical Features of CT Images of Paediatric Patients with COVID-19.']
2020.03.12.20034686-p17-91-4.png,Patient 125,1,China (Unspecified Region),1,N/A,,day 4-5 after admission,mild,,10.1101/2020.03.12.20034686,['Fig 2. Typical Features of CT Images of Paediatric Patients with COVID-19.']
2020.03.12.20034686-p17-91-3.png,Patient 124,1,China (Unspecified Region),1,N/A,,day 4-5 after admission,mild,,10.1101/2020.03.12.20034686,['Fig 2. Typical Features of CT Images of Paediatric Patients with COVID-19.']
2020.03.10.20032136-p34-118_2%1.png,Patient 116,1,China (Unspecified Region),33,N/A,,day 14,mild,,10.1101/2020.03.10.20032136,"['Figure 1. Chest computed tomographic (CT) images for study patients infected with COVID-19. Panel A depicted the chest CT images for a patient aged 21 years on day 10 after illness onset, and Panel B depicted the chest CT images for a patient aged 33 years on day 14 after illness onset.']"
2020.03.10.20032136-p34-118_2%0.png,Patient 116,1,China (Unspecified Region),33,N/A,,day 14,mild,,10.1101/2020.03.10.20032136,"['Figure 1. Chest computed tomographic (CT) images for study patients infected with COVID-19. Panel A depicted the chest CT images for a patient aged 21 years on day 10 after illness onset, and Panel B depicted the chest CT images for a patient aged 33 years on day 14 after illness onset.']"
2020.03.10.20032136-p34-118_1%1.png,Patient 115,1,China (Unspecified Region),21,N/A,,day 10,mild,,10.1101/2020.03.10.20032136,"['Figure 1. Chest computed tomographic (CT) images for study patients infected with COVID-19. Panel A depicted the chest CT images for a patient aged 21 years on day 10 after illness onset, and Panel B depicted the chest CT images for a patient aged 33 years on day 14 after illness onset.']"
2020.03.10.20032136-p34-118_1%0.png,Patient 115,1,China (Unspecified Region),21,N/A,,day 10,mild,,10.1101/2020.03.10.20032136,"['Figure 1. Chest computed tomographic (CT) images for study patients infected with COVID-19. Panel A depicted the chest CT images for a patient aged 21 years on day 10 after illness onset, and Panel B depicted the chest CT images for a patient aged 33 years on day 14 after illness onset.']"
2020.03.08.20031658-p15-106.png,Patient 110,1,China (Unspecified Region),N/A,N/A,,,severe,bilateral patchy patterns,10.1101/2020.03.08.20031658,['Figure 1. Representative chest radiographic manifestations in mild and severe cases with COVID-19. ']
2020.03.08.20031658-p15-105.png,Patient 109,1,China (Unspecified Region),N/A,N/A,,,severe,bilateral patchy patterns,10.1101/2020.03.08.20031658,['Figure 1. Representative chest radiographic manifestations in mild and severe cases with COVID-19. ']
2020.03.08.20031658-p15-104.png,Patient 108,1,China (Unspecified Region),N/A,N/A,,,mild,bilateral patchy patterns,10.1101/2020.03.08.20031658,['Figure 1. Representative chest radiographic manifestations in mild and severe cases with COVID-19. ']
2020.03.08.20031658-p15-103.png,Patient 107,1,China (Unspecified Region),N/A,N/A,,,mild,bilateral patchy patterns,10.1101/2020.03.08.20031658,['Figure 1. Representative chest radiographic manifestations in mild and severe cases with COVID-19. ']
2020.03.01.20029769-p21-73_4.png,Patient 73,1,China (Unspecified Region),N/A,N/A,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (B) Three patients showed elevated IL-6 after treatment, which is associated with disease exacerbation and progressed CT imaging. ']"
2020.03.01.20029769-p21-73_3.png,Patient 72,1,China (Unspecified Region),N/A,N/A,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (B) Three patients showed elevated IL-6 after treatment, which is associated with disease exacerbation and progressed CT imaging. ']"
2020.03.01.20029769-p21-73_2%2.png,Patient 71,1,China (Unspecified Region),N/A,N/A,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (A) The elevated baseline IL-6 was correlated with the severity assessed by chest computed tomography (CT) scan, and the decrease in IL-6 after treatment was positively correlated with the improvement in chest CT images. ']"
2020.03.01.20029769-p21-73_2%1.png,Patient 70,1,China (Unspecified Region),N/A,N/A,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (A) The elevated baseline IL-6 was correlated with the severity assessed by chest computed tomography (CT) scan, and the decrease in IL-6 after treatment was positively correlated with the improvement in chest CT images. ']"
2020.03.01.20029769-p21-73_2%0.png,Patient 69,1,China (Unspecified Region),N/A,N/A,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (A) The elevated baseline IL-6 was correlated with the severity assessed by chest computed tomography (CT) scan, and the decrease in IL-6 after treatment was positively correlated with the improvement in chest CT images. ']"
2020.03.01.20029769-p21-73_1%2.png,Patient 68,1,China (Unspecified Region),69,F,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (A) The elevated baseline IL-6 was correlated with the severity assessed by chest computed tomography (CT) scan, and the decrease in IL-6 after treatment was positively correlated with the improvement in chest CT images. ']"
2020.03.01.20029769-p21-73_1%1.png,Patient 67,1,China (Unspecified Region),N/A,N/A,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (A) The elevated baseline IL-6 was correlated with the severity assessed by chest computed tomography (CT) scan, and the decrease in IL-6 after treatment was positively correlated with the improvement in chest CT images. ']"
2020.03.01.20029769-p21-73_1%0.png,Patient 66,1,China (Unspecified Region),N/A,N/A,,,severe,,10.1101/2020.03.01.20029769,"['Figure 4 Variation in IL-6 and chest computed tomography in severe COVID-19 patients. (A) The elevated baseline IL-6 was correlated with the severity assessed by chest computed tomography (CT) scan, and the decrease in IL-6 after treatment was positively correlated with the improvement in chest CT images. ']"
2020.02.28.20029025-p23-183.png,Patient 65,1,China (Unspecified Region),N/A,N/A,,,mild,,10.1101/2020.02.28.20029025,"['Figure 7. Patient case CT scan. B: Patient ID 19, the nucleic acid detection result was positive, but the IgM and IgG results were negative, no obvious lesion was found in both lungs. ']"
2020.02.28.20029025-p23-182.png,Patient 64,1,China (Unspecified Region),N/A,N/A,,,mild,,10.1101/2020.02.28.20029025,"['Figure 7. Patient case CT scan. A: Patient ID 55, the nucleic acid detection result was negative, but the IgM and IgG results were positive. In the lower of both lungs, there were large fuzzy shadows and GGO, some slightly fan-shaped distribution. ']"
2020.03.03.20030775-p12-93%1.png,Patient 81,1,"Guangdon, China",57,M,,,mild,,10.1101/2020.03.03.20030775,"['Figure5. 68-year old female as serve NCP patients with history of recent travel to Wuhan, presenting with fever and productive cough. Axial thin-section non-contrast CT image shows diffusion lesions in bilateral lung. A showed many CT features such as ground-glass opacification, cobblestone/reticular pattern (blue arrow and blue line around region), fibrosis and dilated bronchi with thickened wall (the enlarged image in the upper right corner, red arrow). B showed consolidation (pink arrow) and mixed pattern (yellow arrow and yellow line around region) in the bilateral lower lobes.']"
2020.03.03.20030775-p12-93%0.png,Patient 81,1,"Guangdon, China",57,M,,,mild,,10.1101/2020.03.03.20030775,"['Figure5. 68-year old female as serve NCP patients with history of recent travel to Wuhan, presenting with fever and productive cough. Axial thin-section non-contrast CT image shows diffusion lesions in bilateral lung. A showed many CT features such as ground-glass opacification, cobblestone/reticular pattern (blue arrow and blue line around region), fibrosis and dilated bronchi with thickened wall (the enlarged image in the upper right corner, red arrow). B showed consolidation (pink arrow) and mixed pattern (yellow arrow and yellow line around region) in the bilateral lower lobes.']"
2020.03.03.20030775-p11-91.png,Patient 80,1,"Guangdon, China",76,M,,,severe,,10.1101/2020.03.03.20030775,"['Figure 3. 76-year old man with history of recent travel to Wuhan, presenting with fever and productive cough. Axial thin-section non-contrast CT image shows diffusion lesions in bilateral lung, mainly manifested as ground-glass opacification (red arrow and red line around region), and cobble stone/Reticular pattern (blue arrow and blue line around region). Besides, Vascular enlargement sign was observed in the lesions (yellow arrow).']"
2020.03.03.20030775-p10-88%1.png,Patient 78,1,"Guangdon, China",57,M,,,severe,,10.1101/2020.03.03.20030775,"['Figure2. 57-year old man with history of recent travel to Wuhan, presenting with fever, cough and shortness of breath. Axial thin-section non-contrast CT scan shows diffuse bilateral confluent and patchy ground-glass, air-bronchogram and consolidation, characterized by peripheral distribution. Multiple lobes were involved.']"
2020.03.03.20030775-p10-88%0.png,Patient 78,1,"Guangdon, China",57,M,,,severe,,10.1101/2020.03.03.20030775,"['Figure2. 57-year old man with history of recent travel to Wuhan, presenting with fever, cough and shortness of breath. Axial thin-section non-contrast CT scan shows diffuse bilateral confluent and patchy ground-glass, air-bronchogram and consolidation, characterized by peripheral distribution. Multiple lobes were involved.']"
2020.03.19.20038539-p10-62.png,Patient 145,1,"Hainan, China",50,N/A," fibrous cord shadows in both lungs, and the absorption of inflammation. ",23 days,severe ,,,['Figure 2. Chest Computed Tomographic Images of a 50-Year-Old Severe Patient Infected With Coronavirus Disease 2019. ']
2020.03.19.20038539-p10-61.png,Patient 145,1,"Hainan, China",50,N/A," fibrous cord shadows in both lungs, and the absorption of inflammation. ",23 days,severe ,,,['Figure 2. Chest Computed Tomographic Images of a 50-Year-Old Severe Patient Infected With Coronavirus Disease 2019. ']
2020.03.19.20038539-p10-60.png,Patient 145,1,"Hainan, China",50,N/A," fibrous cord shadows in both lungs, and the absorption of inflammation. ",23 days,severe ,,,['Figure 2. Chest Computed Tomographic Images of a 50-Year-Old Severe Patient Infected With Coronavirus Disease 2019. ']
2020.03.19.20038539-p10-59.png,Patient 145,1,"Hainan, China",50,N/A,ground glass opacity in both lungs on day 10 after symptom onset.,10 days,severe ,,,['Figure 2. Chest Computed Tomographic Images of a 50-Year-Old Severe Patient Infected With Coronavirus Disease 2019. ']
2020.03.19.20038539-p10-58.png,Patient 145,1,"Hainan, China",50,N/A,ground glass opacity in both lungs on day 10 after symptom onset.,10 days,severe ,,,['Figure 2. Chest Computed Tomographic Images of a 50-Year-Old Severe Patient Infected With Coronavirus Disease 2019. ']
2020.03.19.20038539-p10-57.png,Patient 145,1,"Hainan, China",50,N/A,ground glass opacity in both lungs on day 10 after symptom onset.,10 days,severe ,,,['Figure 2. Chest Computed Tomographic Images of a 50-Year-Old Severe Patient Infected With Coronavirus Disease 2019. ']
2020.02.27.20027557-p25-137%4.png,Patient 63,1,"Hubei, China",N/A,N/A,,7 days after DIP treatment,severe,,10.1101/2020.02.27.20027557,['Figure 4. Chest CT images in the axial (left panel) and coronal view (right panel) of represented severe COVID-19 patient before and after receiving DIP adjunctive therapy. (E) Chest CT scan 7 days after DIP treatment.']
2020.02.27.20027557-p25-137%3.png,Patient 63,1,"Hubei, China",N/A,N/A,,2 days after DIP treatment,severe,,10.1101/2020.02.27.20027557,['Figure 4. Chest CT images in the axial (left panel) and coronal view (right panel) of represented severe COVID-19 patient before and after receiving DIP adjunctive therapy. (D) Chest CT scan 2 days after DIP treatment.']
2020.02.27.20027557-p25-137%2.png,Patient 63,1,"Hubei, China",N/A,N/A,,2 days before DIP treatment,severe,,10.1101/2020.02.27.20027557,['Figure 4. Chest CT images in the axial (left panel) and coronal view (right panel) of represented severe COVID-19 patient before and after receiving DIP adjunctive therapy. (C) Chest CT scan 2 days before DIP treatment.']
2020.02.27.20027557-p25-137%1.png,Patient 63,1,"Hubei, China",N/A,N/A,,5 days before DIP treatment,severe,,10.1101/2020.02.27.20027557,['Figure 4. Chest CT images in the axial (left panel) and coronal view (right panel) of represented severe COVID-19 patient before and after receiving DIP adjunctive therapy. (B) Chest CT scan 5 days before DIP treatment.']
2020.02.27.20027557-p25-137%0.png,Patient 63,1,"Hubei, China",N/A,N/A,,10 days before DIP treatment,severe,,10.1101/2020.02.27.20027557,['Figure 4. Chest CT images in the axial (left panel) and coronal view (right panel) of represented severe COVID-19 patient before and after receiving DIP adjunctive therapy. (A) Initial chest CT scan 10 days before DIP treatment.']
2020.02.24.20027201-p19-670.png,Patient 29,1,"Hubei, China",N/A,N/A,,,severe,,,"['Figure 3. Representative images of chest CT scans (the transverse plane). Patients with COVID-19 had unilateral or bilateral pneumonia. The multiple ""ground-glass"" lesions were the characteristics of COVID-19 pneumonia.The green arrows represent the sites of lesions.']"
2020.02.24.20027201-p19-669.png,Patient 28,1,"Hubei, China",N/A,N/A,,,severe,,,"['Figure 3. Representative images of chest CT scans (the transverse plane). Patients with COVID-19 had unilateral or bilateral pneumonia. The multiple ""ground-glass"" lesions were the characteristics of COVID-19 pneumonia.The green arrows represent the sites of lesions.']"
2020.02.22.20024927-p20-70%3.png,Patient 22,1,"Hubei, China",64,M,,,severe,,,['Two cases of CT images from survival group showed ground glass nodular opacities on admission and progressed to multiple patchy ground glass opacities on reexamination. Unilateral ground glass nodular opacity was found on CT images of a 64-year-old man from survival group (C) and progressed patchy ground glass opacities as well as interlobular septal thickening were seen after 4 days (D). ']
2020.02.22.20024927-p20-70%2.png,Patient 22,1,"Hubei, China",64,M,,,severe,,,['Two cases of CT images from survival group showed ground glass nodular opacities on admission and progressed to multiple patchy ground glass opacities on reexamination. Unilateral ground glass nodular opacity was found on CT images of a 64-year-old man from survival group (C) and progressed patchy ground glass opacities as well as interlobular septal thickening were seen after 4 days (D). ']
2020.02.22.20024927-p20-70%1.png,Patient 21,1,"Hubei, China",60,F,,,severe,,,['Two cases of CT images from survival group showed ground glass nodular opacities on admission and progressed to multiple patchy ground glass opacities on reexamination. The CT images of a 60-year-old woman on admission showed peripherally distributed focal ground glass nodular opacities in only right lung (A) and rechecked CT images showed expanded area of patchy ground glass opacities in both right and left lungs with reticular and interlobular septal thickening on 7 days later (B). ']
2020.02.22.20024927-p20-70%0.png,Patient 21,1,"Hubei, China",60,F,,,severe,,,['Two cases of CT images from survival group showed ground glass nodular opacities on admission and progressed to multiple patchy ground glass opacities on reexamination. The CT images of a 60-year-old woman on admission showed peripherally distributed focal ground glass nodular opacities in only right lung (A) and rechecked CT images showed expanded area of patchy ground glass opacities in both right and left lungs with reticular and interlobular septal thickening on 7 days later (B). ']
2020.02.22.20024927-p19-68%5.png,Patient 20,1,"Hubei, China",72,F,,,critical,,,"['Air bronchogram, together with extensive of consolidations and ground glass opacities were found in the CT images of a 72–year-old woman from mortality group (D-F).']"
2020.02.22.20024927-p19-68%4.png,Patient 20,1,"Hubei, China",72,F,,,critical,,,"['Air bronchogram, together with extensive of consolidations and ground glass opacities were found in the CT images of a 72–year-old woman from mortality group (D-F).']"
2020.02.22.20024927-p19-68%3.png,Patient 20,1,"Hubei, China",72,F,,,critical,,,"['Air bronchogram, together with extensive of consolidations and ground glass opacities were found in the CT images of a 72–year-old woman from mortality group (D-F).']"
2020.02.22.20024927-p19-68%2.png,Patient 19,1,"Hubei, China",76,F,,,critical,,,['CT images of a 76-year-old woman from survival group showed pure ground glass opacities with predominant peripheral distribution in middle and lower lung zones (A-C).']
2020.02.22.20024927-p19-68%1.png,Patient 19,1,"Hubei, China",76,F,,,critical,,,['CT images of a 76-year-old woman from survival group showed pure ground glass opacities with predominant peripheral distribution in middle and lower lung zones (A-C).']
2020.02.22.20024927-p19-68%0.png,Patient 19,1,"Hubei, China",76,F,,,critical,,,['CT images of a 76-year-old woman from survival group showed pure ground glass opacities with predominant peripheral distribution in middle and lower lung zones (A-C).']
2020.02.22.20024927-p18-66%2.png,Patient 18,1,"Hubei, China",63,F,,,critical,,,"['A sample scoring on CT images of a 63-year-old woman from mortality group demonstrated a total score of 63. It was calculated as: for upper zone (C), 3 (consolidation) × (2 (25-50% distribution of the right lung) + 3 (50-75% distribution of the left lung))  + 2 (ground glass opacity) × (2 (25-50% distribution of the right lung) + 1 (< 25% distribution of the left lung)). ']"
2020.02.22.20024927-p18-66%1.png,Patient 18,1,"Hubei, China",63,F,,,critical,,,"['A sample scoring on CT images of a 63-year-old woman from mortality group demonstrated a total score of 63. It was calculated as: for upper zone (B), 3 (consolidation) × 2 (25-50% distribution) × 2 (both right and left lungs) + 2 (ground glass opacity) × 2 (25-50% distribution) × 2 (both right and left lungs) ; for lower zone. ']"
2020.02.22.20024927-p18-66%0.png,Patient 18,1,"Hubei, China",63,F,,,critical,,,"['A sample scoring on CT images of a 63-year-old woman from mortality group demonstrated a total score of 63. It was calculated as: for upper zone (A), 3 (consolidation) × 3 (50-75% distribution) × 2 (both right and left lungs) + 2 (ground glass opacity) ×1 (< 25% distribution) × 2 (both right and left lungs); for middle zone. ']"
2020.02.19.20025023-p20-93%3.png,Patient 17,1,"Hubei, China",N/A,N/A,,,severe,,,['Figure 1. Chest computed tomographic images of patients with coronavirus disease 2019 (D) Severe cases were characterized by typical white lung change as high-density mass shadows and multiple lobular consolidations were observed.']
2020.02.19.20025023-p20-93%2.png,Patient 16,1,"Hubei, China",N/A,N/A,,,severe,,,['Figure 1. Chest computed tomographic images of patients with coronavirus disease 2019 (B-C) Transverse chest CT images of moderate patients showing large ground-glass opacities and some with ambiguous borderline.']
2020.02.19.20025023-p20-93%1.png,Patient 15,1,"Hubei, China",N/A,N/A,,,moderate,,,['Figure 1. Chest computed tomographic images of patients with coronavirus disease 2019 (B-C) Transverse chest CT images of moderate patients showing large ground-glass opacities and some with ambiguous borderline.']
2020.02.19.20025023-p20-93%0.png,Patient 14,1,"Hubei, China",N/A,N/A,,,moderate,,,['Figure 1. Chest computed tomographic images of patients with coronavirus disease 2019 (A) Mild pneumonia patient showed patchy ground-glass opacity with clear borderline in a transverse chest CT image.']
2020.03.04.20026005-p12-1946%5.png,Patient 83,1,"Hunan, China",37,N/A,,day 21,severe,,10.1101/2020.03.04.20026005,['Figure 2 Chest Computed Tomographic Images of two Discharged Patients of Serious Conditions Infected With NCP. Follow-up CT images at 21 day show most of the lesions were absorbed and some of them showed changes of pulmonary interstitial fibrosis (F). ']
2020.03.04.20026005-p12-1946%4.png,Patient 83,1,"Hunan, China",37,N/A,,day 9,severe,,10.1101/2020.03.04.20026005,"['Figure 2 Chest Computed Tomographic Images of two Discharged Patients of Serious Conditions Infected With NCP. After the disease progressed, Follow-up CT images at 9 day show pulmonary consolidation occurred, from peripheral pulmonary parenchyma to the central lung interstitium (E). ']"
2020.03.04.20026005-p12-1946%3.png,Patient 83,1,"Hunan, China",37,N/A,,,severe,,10.1101/2020.03.04.20026005,"['Figure 2 Chest Computed Tomographic Images of two Discharged Patients of Serious Conditions Infected With NCP. Baseline CT images at admission of the second discharged patient (IP: C54, 37years) show multiple patchy pure ground glass opacity (GGO), GGO with reticular and/or interlobular septal thickening (D). ']"
2020.03.04.20026005-p12-1946%2.png,Patient 82,1,"Hunan, China",57,N/A,,day 21,severe,,10.1101/2020.03.04.20026005,['Figure 2 Chest Computed Tomographic Images of two Discharged Patients of Serious Conditions Infected With NCP. Follow-up CT images at 21 day show most of the lesions were absorbed and some of them showed changes of pulmonary interstitial fibrosis (C). ']
2020.03.04.20026005-p12-1946%1.png,Patient 82,1,"Hunan, China",57,N/A,,day 7,severe,,10.1101/2020.03.04.20026005,"['Figure 2 Chest Computed Tomographic Images of two Discharged Patients of Serious Conditions Infected With NCP. After the disease progressed, Follow-up CT images at 7 day show pulmonary consolidation occurred, lung parenchyma from peripheral to the central lung interstitium (B). ']"
2020.03.04.20026005-p12-1946%0.png,Patient 82,1,"Hunan, China",57,N/A,,,severe,,10.1101/2020.03.04.20026005,"['Figure 2 Chest Computed Tomographic Images of two Discharged Patients of Serious Conditions Infected With NCP. Baseline CT images at admission of the first discharged patient (IP: C56, 57 years) show multiple patchy pure ground glass opacity (GGO), GGO with reticular and/or interlobular septal thickening (A). ']"
2020.03.03.20030353-p17-106%2.png,Patient 76,1,"Hunan, China",N/A,N/A,,,severe,,10.1101/2020.03.03.20030353,['Figure 1. The typical manifestations in CT and chest X-ray for patients with COVID-19. Cross-sectional CT shows (C) Ground glass opacity in bilateral upper lobe.  ']
2020.03.03.20030353-p17-106%1.png,Patient 75,1,"Hunan, China",N/A,N/A,,,severe,,10.1101/2020.03.03.20030353,['Figure 1. The typical manifestations in CT and chest X-ray for patients with COVID-19. Cross-sectional CT shows (B) large areas of consolidation with air bronchogram sign in right upper lobe.  ']
2020.03.03.20030353-p17-106%0.png,Patient 74,1,"Hunan, China",N/A,N/A,,,severe,,10.1101/2020.03.03.20030353,['Figure 1. The typical manifestations in CT and chest X-ray for patients with COVID-19. Cross-sectional CT shows (A) patchy consolidation abutting the pleura in left upper lobe.  ']
2020.03.07.20031393-p7-50%3.png,Patient 106,1,"Jingmen, Hubei, China",N/A,N/A,,,asymptomatic,,10.1101/2020.03.07.20031393,"['Figure 4: Chest CTs of a asymptomatic patient, obtained on Fab 10 showed small patchy high density shadows and ground glass shadows in the lower lobe of the right lung near the pleural surface.']"
2020.03.07.20031393-p7-50%2.png,Patient 106,1,"Jingmen, Hubei, China",N/A,N/A,,,asymptomatic,,10.1101/2020.03.07.20031393,"['Figure 4: Chest CTs of a asymptomatic patient, obtained on Fab 10 showed small patchy high density shadows and ground glass shadows in the lower lobe of the right lung near the pleural surface.']"
2020.03.07.20031393-p7-50%1.png,Patient 106,1,"Jingmen, Hubei, China",N/A,N/A,,,asymptomatic,,10.1101/2020.03.07.20031393,"['Figure 4: Chest CTs of a asymptomatic patient, obtained on Fab 10 showed small patchy high density shadows and ground glass shadows in the lower lobe of the right lung near the pleural surface.']"
2020.03.07.20031393-p7-50%0.png,Patient 106,1,"Jingmen, Hubei, China",N/A,N/A,,,asymptomatic,,10.1101/2020.03.07.20031393,"['Figure 4: Chest CTs of a asymptomatic patient, obtained on Fab 10 showed small patchy high density shadows and ground glass shadows in the lower lobe of the right lung near the pleural surface.']"
2020.03.11.20033159-p12-45%3.png,Patient 118,1,"Qingdao, China",N/A,N/A,,day 13,moderate,,10.1101/2020.03.11.20033159,['Figure 1. Transverse Chest Computed Tomographic Images. Complete resolution of lesion was observed after treatment for 13 days (2B).']
2020.03.11.20033159-p12-45%2.png,Patient 118,1,"Qingdao, China",N/A,N/A,,first day,moderate,,10.1101/2020.03.11.20033159,"['Figure 1. Transverse Chest Computed Tomographic Images. Case 2 showed ground glass consolidation of the left lower lobe near the pleura on Admission (2A, red arrow).']"
2020.03.11.20033159-p12-45%1.png,Patient 117,1,"Qingdao, China",N/A,N/A,,day 10,moderate,,10.1101/2020.03.11.20033159,"['Figure 1. Transverse Chest Computed Tomographic Images. After receiving treatment for 10 days, the lesions were completely absorbed(1B).']"
2020.03.11.20033159-p12-45%0.png,Patient 117,1,"Qingdao, China",N/A,N/A,,day 1,moderate,,10.1101/2020.03.11.20033159,"['Figure 1. Transverse Chest Computed Tomographic Images. CT image from case 1 on day 1 after symptom onset, showing delicate patches of ground glass opacity of lower lobe of right lung near the pleura (1A, red arrow).']"
2020.03.04.20030395-p27-108%8.png,Patient 92,1,"Shanghai, China",N/A,N/A,,,moderate,,10.1101/2020.03.04.20030395,['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 9. Bilateral diffuse consolidation with air bronchograms.']
2020.03.04.20030395-p27-108%7.png,Patient 91,1,"Shanghai, China",N/A,N/A,,,moderate,,10.1101/2020.03.04.20030395,['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 8. Bilateral diffuse consolidation with air bronchograms in the lower lobes. Multiple areas of patchy consolidation in the right middle lobe. ']
2020.03.04.20030395-p27-108%6.png,Patient 90,1,"Shanghai, China",N/A,N/A,,,severe,,10.1101/2020.03.04.20030395,['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 7. Diffuse consolidation in the right lower lobe. Ground glass opacity with partial consolidation in multiple lobes of left lung.']
2020.03.04.20030395-p27-108%5.png,Patient 89,1,"Shanghai, China",N/A,N/A,,,severe,,10.1101/2020.03.04.20030395,"['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 6. Bilateral consolidation in the subpleural region of lower lobes, with parenchymal bands. Air bronchograms are present in the right lower lobe.']"
2020.03.04.20030395-p27-108%4.png,Patient 88,1,"Shanghai, China",N/A,N/A,,,severe,,10.1101/2020.03.04.20030395,"['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 5. Bilateral consolidation in the peripheral regions of the upper lobes, with inter- and intra-lobular septal thickening (crazy paving pattern).']"
2020.03.04.20030395-p27-108%3.png,Patient 87,1,"Shanghai, China",N/A,N/A,,,severe,,10.1101/2020.03.04.20030395,"['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 4. Bilateral multilobular ground glass opacity and partial consolidation, and a pneumatocele in the right upper lobe. ']"
2020.03.04.20030395-p27-108%2.png,Patient 86,1,"Shanghai, China",N/A,N/A,,,severe,,10.1101/2020.03.04.20030395,['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 3. A small region of subpleural consolidation in the posterior right upper lobe.  ']
2020.03.04.20030395-p27-108%1.png,Patient 85,1,"Shanghai, China",N/A,N/A,,,severe,,10.1101/2020.03.04.20030395,['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 2. A small region of subpleural ground glass opacity with partial consolidation in the right lower lobe. ']
2020.03.04.20030395-p27-108%0.png,Patient 84,1,"Shanghai, China",N/A,N/A,,,severe,,10.1101/2020.03.04.20030395,['Figure 1. Representative chest CT images from multiple patients. Various radiographic abnormalities are present as follows: 1. Intralobular septal thickening and parenchymal bands in the right lower lobe.']
2020.02.13.20022673-p13-77%2.png,Patient 12,1,"Shanghai, China",N/A,N/A,,,severe,,,['Figure 2. Chest computed tomographic Images of patients with SARS-CoV-2 and other pathogens. ']
2020.02.13.20022673-p13-77%1.png,Patient 11,1,"Shanghai, China",N/A,N/A,,,severe,,,['Figure 2. Chest computed tomographic Images of patients with SARS-CoV-2 and other pathogens. ']
2020.02.13.20022673-p13-77%0.png,Patient 10,1,"Shanghai, China",N/A,N/A,,,severe,,,['Figure 2. Chest computed tomographic Images of patients with SARS-CoV-2 and other pathogens. ']
2020.02.17.20024018-p17-61%4.png,Patient 13,1,"Shenzhen, China",36,F,,15th day of the course of disease,severe,,,"['The Imageology change with the disease progression of a 36 years-old female severe patient infected with 2019-CoV A and B were second day of the course of disease; C and D were day 7; E was day 11 and F was day 15. E. Multiple patchy shadows with fuzzy edges were observed, and large ground glass shadow and condensation shadow were found in both lower lobe.']"
2020.02.17.20024018-p17-61%3.png,Patient 13,1,"Shenzhen, China",36,F,,11th day of the course of disease,severe,,,['The Imageology change with the disease progression of a 36 years-old female severe patient infected with 2019-CoV A and B were second day of the course of disease; C and D were day 7; E was day 11 and F was day 15. D. Progress to patchy shadow with uneven density.']
2020.02.17.20024018-p17-61%2.png,Patient 13,1,"Shenzhen, China",36,F,,7th day of the course of disease,severe,,,"['The Imageology change with the disease progression of a 36 years-old female severe patient infected with 2019-CoV A and B were second day of the course of disease; C and D were day 7; E was day 11 and F was day 15. C. Ground glass shadow of both lungs, left pulmonary nodule focus located under pleura.']"
2020.02.17.20024018-p17-61%1.png,Patient 13,1,"Shenzhen, China",36,F,,2nd day of the course of disease,severe,,,['The Imageology change with the disease progression of a 36 years-old female severe patient infected with 2019-CoV A and B were second day of the course of disease; C and D were day 7; E was day 11 and F was day 15. B. Thin ground glass shadow Mainly distributed in outer zone of the lung and under the pleura.']
2020.02.17.20024018-p17-61%0.png,Patient 13,1,"Shenzhen, China",36,F,,2nd day of the course of disease,severe,,,['The Imageology change with the disease progression of a 36 years-old female severe patient infected with 2019-CoV A and B were second day of the course of disease; C and D were day 7; E was day 11 and F was day 15. A. CT showed local ground glass shadow and nodules.']
2020.02.11.20021493-p16-109%2.png,Patient 5,1,"Shenzhen, China",36,M,without any underling diseases ,,moderate,,,"['Figure 2. Computed tomography (CT) scan of the cases 02, 07 and 13.']"
2020.02.11.20021493-p16-109%1.png,Patient 4,1,"Shenzhen, China",34,M,,,severe,,,"['Figure 2. Computed tomography (CT) scan of the cases 02, 07 and 13.']"
2020.02.11.20021493-p16-109%0.png,Patient 3,1,"Shenzhen, China",65,F,hypertension,,severe,,,"['Figure 2. Computed tomography (CT) scan of the cases 02, 07 and 13.']"
2020.02.11.20022053-p12-67%3.png,Patient 9,1,"Sichuan, China",34,M,,,moderate,,,"['Figure. Chest Computed tomography (CT) images of patients infected with 2019-nCoV on admission to hospital. D, Chest CT scan taken on January 23, 2020, from a 34-year-old man (discharged after treatment on day 11), showing patchy shadows.']"
2020.02.11.20022053-p12-67%2.png,Patient 8,1,"Sichuan, China",48,M,,,moderate,,,"['Figure. Chest Computed tomography (CT) images of patients infected with 2019-nCoV on admission to hospital. C, Chest CT scan taken on January 27, 2020, from a 48-year-old man (discharged after treatment on day 9), showing patchy shadows.']"
2020.02.11.20022053-p12-67%1.png,Patient 7,1,"Sichuan, China",45,M,,,moderate,,,"['Figure. Chest Computed tomography (CT) images of patients infected with 2019-nCoV on admission to hospital. B, Chest CT scan obtained on February 6, 2020, from a 45-year-old man, showing bilateral ground glass opacities.']"
2020.02.11.20022053-p12-67%0.png,Patient 6,1,"Sichuan, China",39,M,,,moderate,,,"['Figure. Chest Computed tomography (CT) images of patients infected with 2019-nCoV on admission to hospital. A, Chest CT scan obtained on February 2, 2020, from a 39-year-old man, showing bilateral ground glass opacities.']"
2020.03.16.20035105-p6-64-4.png,Patient 140,1,"Wuhan, China",66,M,,,moderate,,10.1101/2020.03.16.20035105,"['Figure 1. Chest CT imaging of the patient with COVID-19. Chest CT showed patchy high-density blurred shadow in the upper lobe of the left lung (Figure 1A) and patchy ground glass shadow in the anterior segment of the upper lobe of the right lung (Figure 1B). After treatment, chest CT showed that the previous lesions were almost absorbed. ']"
2020.03.16.20035105-p6-64-3.png,Patient 140,1,"Wuhan, China",66,M,,,severe,,10.1101/2020.03.16.20035105,"['Figure 1. Chest CT imaging of the patient with COVID-19. Chest CT showed patchy high-density blurred shadow in the upper lobe of the left lung (Figure 1A) and patchy ground glass shadow in the anterior segment of the upper lobe of the right lung (Figure 1B). After treatment, chest CT showed that the previous lesions were almost absorbed. ']"
2020.03.16.20035105-p6-64-2.png,Patient 140,1,"Wuhan, China",66,M,,day 5,mild,,10.1101/2020.03.16.20035105,"['Figure 1. Chest CT imaging of the patient with COVID-19. Chest CT showed patchy high-density blurred shadow in the upper lobe of the left lung (Figure 1A) and patchy ground glass shadow in the anterior segment of the upper lobe of the right lung (Figure 1B). After treatment, chest CT showed that the previous lesions were almost absorbed. ']"
2020.03.16.20035105-p6-64-1.png,Patient 140,1,"Wuhan, China",66,M,,day 5,moderate,,10.1101/2020.03.16.20035105,"['Figure 1. Chest CT imaging of the patient with COVID-19. Chest CT showed patchy high-density blurred shadow in the upper lobe of the left lung (Figure 1A) and patchy ground glass shadow in the anterior segment of the upper lobe of the right lung (Figure 1B). After treatment, chest CT showed that the previous lesions were almost absorbed. ']"
2020.02.26.20027938-p6-80_3%1.png,Patient 62,1,"Wuhan, China",N/A,N/A,,day 18,moderate,,10.1101/2020.02.26.20027938,"['Fig. 3 Clinical photographs of the positive patient regarding conjunctivitis and chest CT: (D-F)dynamic changes of peripheral ground-glass opacities in both lungs (yellow arrows) which illuminate the pneumonia caused by SARS-COV-2 infection.The pulmonary lesions were aggravated on the 10th day, and the lesions were basically absorbed on the 18th day. ']"
2020.02.26.20027938-p6-80_3%0.png,Patient 62,1,"Wuhan, China",N/A,N/A,,day 10,moderate,,10.1101/2020.02.26.20027938,"['Fig. 3 Clinical photographs of the positive patient regarding conjunctivitis and chest CT: (D-F)dynamic changes of peripheral ground-glass opacities in both lungs (yellow arrows) which illuminate the pneumonia caused by SARS-COV-2 infection.The pulmonary lesions were aggravated on the 10th day, and the lesions were basically absorbed on the 18th day. ']"
2020.02.26.20027938-p6-80_2%1.png,Patient 62,1,"Wuhan, China",N/A,N/A,,day 2,moderate,,10.1101/2020.02.26.20027938,"['Fig. 3 Clinical photographs of the positive patient regarding conjunctivitis and chest CT: (D-F)dynamic changes of peripheral ground-glass opacities in both lungs (yellow arrows) which illuminate the pneumonia caused by SARS-COV-2 infection.The pulmonary lesions were aggravated on the 10th day, and the lesions were basically absorbed on the 18th day. ']"
2020.02.26.20027938-p6-80_2%0.png,Patient 62,1,"Wuhan, China",N/A,N/A,,day 18,moderate,,10.1101/2020.02.26.20027938,"['Fig. 3 Clinical photographs of the positive patient regarding conjunctivitis and chest CT: (D-F)dynamic changes of peripheral ground-glass opacities in both lungs (yellow arrows) which illuminate the pneumonia caused by SARS-COV-2 infection.The pulmonary lesions were aggravated on the 10th day, and the lesions were basically absorbed on the 18th day. ']"
2020.02.26.20027938-p6-80_1%1.png,Patient 62,1,"Wuhan, China",N/A,N/A,,day 10,moderate,,10.1101/2020.02.26.20027938,"['Fig. 3 Clinical photographs of the positive patient regarding conjunctivitis and chest CT: (D-F)dynamic changes of peripheral ground-glass opacities in both lungs (yellow arrows) which illuminate the pneumonia caused by SARS-COV-2 infection.The pulmonary lesions were aggravated on the 10th day, and the lesions were basically absorbed on the 18th day. ']"
2020.02.26.20027938-p6-80_1%0.png,Patient 62,1,"Wuhan, China",N/A,N/A,,day 2,moderate,,10.1101/2020.02.26.20027938,"['Fig. 3 Clinical photographs of the positive patient regarding conjunctivitis and chest CT: (D-F)dynamic changes of peripheral ground-glass opacities in both lungs (yellow arrows) which illuminate the pneumonia caused by SARS-COV-2 infection.The pulmonary lesions were aggravated on the 10th day, and the lesions were basically absorbed on the 18th day. ']"
2020.02.25.20021568-p24-111%9.png,Patient 55,1,"Wuhan, China",N/A,N/A,,,moderate,,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. B. CT images of the control. The first image is an ordinary bacterial pneumonia, showing a consolidation of the right lower lobe. The second image has a tumorous lesion in the lung, showing a mass in the left upper lobe, with burrs seen at the edges, and showing leaf-like growth with vacuoles inside. The third image is a secondary pulmonary tuberculosis, showing a left apical fibrous cord. The fourth image is a bronchiectasis complicated with infection, showing bronchodilation and expansion, cystic changes, and surrounding patches of infection. The fifth image shows normal lungs. ']"
2020.02.25.20021568-p24-111%8.png,Patient 54,1,"Wuhan, China",N/A,N/A,,,moderate,bronchiectasis complicated with infection,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. B. CT images of the control. The first image is an ordinary bacterial pneumonia, showing a consolidation of the right lower lobe. The second image has a tumorous lesion in the lung, showing a mass in the left upper lobe, with burrs seen at the edges, and showing leaf-like growth with vacuoles inside. The third image is a secondary pulmonary tuberculosis, showing a left apical fibrous cord. The fourth image is a bronchiectasis complicated with infection, showing bronchodilation and expansion, cystic changes, and surrounding patches of infection. The fifth image shows normal lungs. ']"
2020.02.25.20021568-p24-111%7.png,Patient 53,1,"Wuhan, China",N/A,N/A,,,severe,secondary pulmonary tuberculosis,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. B. CT images of the control. The first image is an ordinary bacterial pneumonia, showing a consolidation of the right lower lobe. The second image has a tumorous lesion in the lung, showing a mass in the left upper lobe, with burrs seen at the edges, and showing leaf-like growth with vacuoles inside. The third image is a secondary pulmonary tuberculosis, showing a left apical fibrous cord. The fourth image is a bronchiectasis complicated with infection, showing bronchodilation and expansion, cystic changes, and surrounding patches of infection. The fifth image shows normal lungs. ']"
2020.02.25.20021568-p24-111%6.png,Patient 52,1,"Wuhan, China",N/A,N/A,,,severe,tumorous lesion in the lung,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. B. CT images of the control. The first image is an ordinary bacterial pneumonia, showing a consolidation of the right lower lobe. The second image has a tumorous lesion in the lung, showing a mass in the left upper lobe, with burrs seen at the edges, and showing leaf-like growth with vacuoles inside. The third image is a secondary pulmonary tuberculosis, showing a left apical fibrous cord. The fourth image is a bronchiectasis complicated with infection, showing bronchodilation and expansion, cystic changes, and surrounding patches of infection. The fifth image shows normal lungs. ']"
2020.02.25.20021568-p24-111%5.png,Patient 51,1,"Wuhan, China",N/A,N/A,,,severe,ordinary bacterial pneumonia,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. B. CT images of the control. The first image is an ordinary bacterial pneumonia, showing a consolidation of the right lower lobe. The second image has a tumorous lesion in the lung, showing a mass in the left upper lobe, with burrs seen at the edges, and showing leaf-like growth with vacuoles inside. The third image is a secondary pulmonary tuberculosis, showing a left apical fibrous cord. The fourth image is a bronchiectasis complicated with infection, showing bronchodilation and expansion, cystic changes, and surrounding patches of infection. The fifth image shows normal lungs. ']"
2020.02.25.20021568-p24-111%4.png,Patient 50,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. A. Computed tomography (CT) images of COVID19 pneumonia. The predictions between the artificial intelligence model and radiologists were consistent. Green boxes, labels from radiologists; red boxes, labels from the model.']"
2020.02.25.20021568-p24-111%3.png,Patient 49,1,"Wuhan, China",N/A,N/A,,,severe,bronchiectasis complicated with infection,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. A. Computed tomography (CT) images of COVID19 pneumonia. The predictions between the artificial intelligence model and radiologists were consistent. Green boxes, labels from radiologists; red boxes, labels from the model.']"
2020.02.25.20021568-p24-111%2.png,Patient 48,1,"Wuhan, China",N/A,N/A,,,severe,secondary pulmonary tuberculosis,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. A. Computed tomography (CT) images of COVID19 pneumonia. The predictions between the artificial intelligence model and radiologists were consistent. Green boxes, labels from radiologists; red boxes, labels from the model.']"
2020.02.25.20021568-p24-111%1.png,Patient 47,1,"Wuhan, China",N/A,N/A,,,severe,tumorous lesion in the lung,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. A. Computed tomography (CT) images of COVID19 pneumonia. The predictions between the artificial intelligence model and radiologists were consistent. Green boxes, labels from radiologists; red boxes, labels from the model.']"
2020.02.25.20021568-p24-111%0.png,Patient 46,1,"Wuhan, China",N/A,N/A,,,severe,ordinary bacterial pneumonia,10.1101/2020.02.25.20021568,"['Figure 4. Representative images of the model's predictions. A. Computed tomography (CT) images of COVID19 pneumonia. The predictions between the artificial intelligence model and radiologists were consistent. Green boxes, labels from radiologists; red boxes, labels from the model.']"
2020.02.25.20021568-p23-108%9.png,Patient 45,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%8.png,Patient 44,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%7.png,Patient 43,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%6.png,Patient 42,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%5.png,Patient 41,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%4.png,Patient 40,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%3.png,Patient 39,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%2.png,Patient 38,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%15.png,Patient 37,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%14.png,Patient 36,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%13.png,Patient 35,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%12.png,Patient 34,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%11.png,Patient 33,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%10.png,Patient 32,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%1.png,Patient 31,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.02.25.20021568-p23-108%0.png,Patient 30,1,"Wuhan, China",N/A,N/A,,,severe,,10.1101/2020.02.25.20021568,"['Figure 3. Processing and prediction schematic of the model. Raw images were firstly input into the model, and after processing of the model, prediction boxes framing suspicious lesions were output. Valid areas were further extracted and unnecessary fields were filter out to avoid possible false positives. To predict by case, a logic linking the prediction results of consecutive images was added. Computed tomography (CT) images with the above prediction results were divided into four quadrants, and results would be output only when three consecutive images were predicted to have lesions in the same quadrant. ']"
2020.01.24.919183-p27-135.png,Patient 1,1,"Wuhan, China",41,M,"no history of hepatitis, tuberculosis or diabetes.",day 6 after the onset of illness,moderate,,,"['Figure 1. Chest radiographs of patient 1. a. b. c. d. Chest computed tomographic scans of Patient 1 were obtained on the day of admission (day 6 after the onset of illness). Bilateral focal consolidation, lobar consolidation, and patchy consolidation were clearly observed, especially in the lower lung. ']"
2020.01.24.919183-p27-134.png,Patient 1,1,"Wuhan, China",41,M,"no history of hepatitis, tuberculosis or diabetes.",day 6 after the onset of illness,moderate,,,"['Figure 1. Chest radiographs of patient 1. a. b. c. d. Chest computed tomographic scans of Patient 1 were obtained on the day of admission (day 6 after the onset of illness). Bilateral focal consolidation, lobar consolidation, and patchy consolidation were clearly observed, especially in the lower lung. ']"
2020.01.24.919183-p27-133.png,Patient 1,1,"Wuhan, China",41,M,"no history of hepatitis, tuberculosis or diabetes.",day 6 after the onset of illness,moderate,,,"['Figure 1. Chest radiographs of patient 1. a. b. c. d. Chest computed tomographic scans of Patient 1 were obtained on the day of admission (day 6 after the onset of illness). Bilateral focal consolidation, lobar consolidation, and patchy consolidation were clearly observed, especially in the lower lung. ']"
2020.01.24.919183-p27-132.png,Patient 1,1,"Wuhan, China",41,M,"no history of hepatitis, tuberculosis or diabetes.",day 6 after the onset of illness,severe,,,"['Figure 1. Chest radiographs of patient 1. a. b. c. d. Chest computed tomographic scans of Patient 1 were obtained on the day of admission (day 6 after the onset of illness). Bilateral focal consolidation, lobar consolidation, and patchy consolidation were clearly observed, especially in the lower lung. ']"
2020.03.22.20034041-p18-92-3.png,Patient 153,1,"Wuhan, China ",40,F,"Feb. 17, 8 days after lopinavir/ritonavir treatment. No significant changes were observed compared to previous CT image. The opacities at tongue-like segment increased. 36.5 °C (Feb. 17)
Slight cough with white sputum (Feb. 17).",,severe,,,"['Figure 4 Patient failed lopinavir/ritonavir plus interferon nebulization and switched to danoprevir/ritonavir without interferon nebulization (Patient 8) GGO, ground-glass opacity. Red arrows indicate the possible lesions. * Viral RNA was undetectable in both nasal and phlegm swabs. ']"
2020.03.22.20034041-p18-92-2.png,Patient 153,1,"Wuhan, China ",40,F,"Feb. 13, 4 days after lopinavir/ritonavir treatment. GGO and patch-shape areas showed a slightly higher density compared to previous CT image. 36.4 °C (Feb. 13)
Diarrhea with yellow thin stool (Feb. 13).",,severe,,,"['Figure 4 Patient failed lopinavir/ritonavir plus interferon nebulization and switched to danoprevir/ritonavir without interferon nebulization (Patient 8) GGO, ground-glass opacity. Red arrows indicate the possible lesions. * Viral RNA was undetectable in both nasal and phlegm swabs. ']"
2020.03.22.20034041-p18-92-1.png,Patient 153,1,"Wuhan, China ",40,F,"Feb. 10, next day after admission to hospital. Subpleural areas of both lower lungs and the tongue-like segment of the left lung showed GGO and patch-shape areas.  
37.4 °C (Feb. 10) Slight cough (Feb. 10).",,severe,,,"['Figure 4 Patient failed lopinavir/ritonavir plus interferon nebulization and switched to danoprevir/ritonavir without interferon nebulization (Patient 8) GGO, ground-glass opacity. Red arrows indicate the possible lesions. * Viral RNA was undetectable in both nasal and phlegm swabs. ']"
2020.03.22.20034041-p17-80-2.png,Patient 152,1,"Wuhan, China ",40,M,"Feb. 17, 3 days after lopinavir/ritonavir treatment. Right lower lung showed further consolidation, along with GGO and patch-shape areas. Weak positive (Feb. 17) Weak positive (Feb. 18). 37 °C (Feb. 17)
Chest distress (Feb. 17).",,severe,,,['Figure 3 Experienced patient treated with lopinavir/ritonavir plus interferon nebulization for 3 days and switched to danoprevir/ritonavir plus interferon nebulization. ']
2020.03.22.20034041-p17-80-1.png,Patient 152,1,"Wuhan, China ",40,M,"Feb. 14, admission to hospital. Subpleural area of the right lower lung showed GGO. 36.5 °C (Feb. 14). Chest distress (Feb. 14).",,severe,,,['Figure 3 Experienced patient treated with lopinavir/ritonavir plus interferon nebulization for 3 days and switched to danoprevir/ritonavir plus interferon nebulization. ']
2020.03.22.20034041-p16-66.png,Patient 151,1,"Wuhan, China ",40,F,"Feb. 20, the next day after admission to hospital. Both lower lungs showed multiple diffuse patch-shape areas and GGO, especially obvious in the left lower lung. 36.4 °C (Feb. 20).",,severe,,,['Figure 2 Natural patient receiving danoprevir/ritonavir plus interferon nebulization (Patient 1)  ']
2020.03.20.20037325-p23-124.png,Patient 149,1,"Wuhan, China ",64,M,symptoms of fever and dyspnoea,3 days,mild,,,"['Figure 4: Representative cases without malignant progression (A, B) and with malignant']"
2020.03.20.20037325-p23-123.png,Patient 148,1,"Wuhan, China ",64,M,symptoms of fever and dyspnoea,3 days,mild,,,"['Figure 4: Representative cases without malignant progression (A, B) and with malignant']"
2020.03.20.20037325-p23-122.png,Patient 147,1,"Wuhan, China ",32,M,"symptoms of fever, cough, and dyspnoea",3 days,mild,,,"['Figure 4: Representative cases without malignant progression (A, B) and with malignant']"
2020.03.20.20037325-p23-121.png,Patient 146,1,"Wuhan, China ",32,M,"symptoms of fever, cough, and dyspnoea",3 days,mild,,,"['Figure 4: Representative cases without malignant progression (A, B) and with malignant']"
2020.03.16.20036145-p19-128-4.png,Patient 142,1,"Wuhan, China ",50,M,"Patient 10, a 50-year-old male, was admitted on 3 dpoi and was given a 200 mL transfusion of CP on 20 dpoi. His chest CT presented massive infiltration and widespread ground-glass attenuation on admission andstarted to show a gradual absorption of lung lesions 5 days after CP transfusion. The SARS-CoV-2 RNA became negative on 25 dpoi. ",29 days,severe,,,['Figure 1.Chest CTs of two patients (D) Chest CTof patient 10 on Feb 18 (29dpoi) showed those lesions improvedafter convalescent plasma transfusion. ']
2020.03.16.20036145-p19-128-3.png,Patient 142,1,"Wuhan, China ",50,M,"Patient 10, a 50-year-old male, was admitted on 3 dpoi and was given a 200 mL transfusion of CP on 20 dpoi. His chest CT presented massive infiltration and widespread ground-glass attenuation on admission andstarted to show a gradual absorption of lung lesions 5 days after CP transfusion. The SARS-CoV-2 RNA became negative on 25 dpoi. ",19 days,severe,,,['Figure 1.Chest CTs of two patients (C)Chest CT of patient 10 was obtained on Feb 8 (19 dpoi) before convalescent plasma transfusion (20 dpoi). The brightness of both lungs was diffusely decreased and multiple shadows of high density in both lungs were observed. ']
2020.03.16.20036145-p19-128-2.png,Patient 141,1,"Wuhan, China ",49,F,"Patient 9, a 49-year-old female admitted on 1 day post onset of illness (dpoi), showed the most obvious pulmonary image improvement. On 10 dpoi, one dose of 200 mL transfusion of CP was given. The SARS-CoV-2 RNA converted to negative on 12 dpoi. Compared with the result on 7 dpoi, massive infiltration and ground-glass attenuation disappeared on CT image performed on 13 dpoi, accompanied bya much better pulmonary function. ",13 days,severe,,,['Figure 1.Chest CTs of two patients (B) CT Image of patient 9 taken on Feb 15(13 dpoi) showed the absorption of bilateral ground glassopacity after convalescent plasma transfusion. ']
2020.03.16.20036145-p19-128-1.png,Patient 141,1,"Wuhan, China ",49,F,"Patient 9, a 49-year-old female admitted on 1 day post onset of illness (dpoi), showed the most obvious pulmonary image improvement. On 10 dpoi, one dose of 200 mL transfusion of CP was given. The SARS-CoV-2 RNA converted to negative on 12 dpoi. Compared with the result on 7 dpoi, massive infiltration and ground-glass attenuation disappeared on CT image performed on 13 dpoi, accompanied bya much better pulmonary function. ",7 days,severe,,,['Figure 1.Chest CTs of two patients (A) Chest CT of patient 9 obtained on Feb 9 (7 dpoi) before convalescent plasma transfusion (10 dpoi)showed ground glass opacity with uneven density involving the multilobal segments of both lungs. The heart shadow outline was not clear. The lesion was close to the pleura.']
2020.03.12.20027185-p8-221.png,Patient 123,1,"Wuhan, China ",N/A,N/A,,,severe,,10.1101/2020.03.12.20027185,['Figure 5: Some accurate and erroneous predictions of the proposed DeCoVNet.']
2020.03.12.20027185-p8-218.png,Patient 122,1,"Wuhan, China ",N/A,N/A,,,severe,,10.1101/2020.03.12.20027185,['Figure 5: Some accurate and erroneous predictions of the proposed DeCoVNet.']
2020.03.12.20027185-p8-217.png,Patient 121,1,"Wuhan, China ",23,F,,,severe,,10.1101/2020.03.12.20027185,['Figure 5: Some accurate and erroneous predictions of the proposed DeCoVNet.']
2020.03.12.20027185-p8-216.png,Patient 120,1,"Wuhan, China ",66,F,,,severe,,10.1101/2020.03.12.20027185,['Figure 5: Some accurate and erroneous predictions of the proposed DeCoVNet.']
2020.03.04.20031039-p23-97_2%2.png,Patient 94,1,"Wuhan, China ",71,N/A,,day 7 ,severe,,10.1101/2020.03.04.20031039,['Figure 1 B: chest CT of two patients.']
2020.03.04.20031039-p23-97_2%1.png,Patient 94,1,"Wuhan, China ",71,N/A,,day 7 ,severe,,10.1101/2020.03.04.20031039,['Figure 1 B: chest CT of two patients.']
2020.03.04.20031039-p23-97_2%0.png,Patient 94,1,"Wuhan, China ",71,N/A,,day 7 ,severe,,10.1101/2020.03.04.20031039,['Figure 1 B: chest CT of two patients.']
2020.03.04.20031039-p23-97_1%2.png,Patient 93,1,"Wuhan, China ",72,N/A,,day 6,severe,,10.1101/2020.03.04.20031039,['Figure 1 A: chest CT of two patients.']
2020.03.04.20031039-p23-97_1%1.png,Patient 93,1,"Wuhan, China ",72,N/A,,day 6,severe,,10.1101/2020.03.04.20031039,['Figure 1 A: chest CT of two patients.']
2020.03.04.20031039-p23-97_1%0.png,Patient 93,1,"Wuhan, China ",72,N/A,,day 6,severe,,10.1101/2020.03.04.20031039,['Figure 1 A: chest CT of two patients.']
2020.03.21.20040691-p18-67-8.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.03.21.20040691-p18-67-7.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.03.21.20040691-p18-67-5.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.03.21.20040691-p18-67-4.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.03.21.20040691-p18-67-3.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.03.21.20040691-p18-67-2.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.03.21.20040691-p18-67-1.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.03.21.20040691-p18-6-6.png,Patient 150,1,"Xi'an, China ",65,M," At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment.",22 days,moderate,,,"['Figure 4: Chest CT image. Transverse chest CT images from a 65-year-old male patient showing bilateral large flaky ground glass shadows and consolidation on baseline period. At day 22, the intrapulmonary lesions were significantly absorbed and dissipated by meplazumab addon treatment. ']"
2020.02.23.20026856-p17-115%5.png,Patient 23,1,"Zhejiang, China ",39,M,,day 7  from symptom onse ,moderate,,,"['Figure 1. Transverse chest CT from a 39 year-old man, showing ground-glass opacities of bilateral lungs near the pleura (a and b) on day 1 from symptom onset, and increased bilateral ground-glass opacities and consolidation(c and d) on day 5  from symptom onset, and slightly absorbed ground-glass opacities (e and f) on day 7 from symptom onset after 7-day treatment.']"
2020.02.23.20026856-p17-115%4.png,Patient 23,1,"Zhejiang, China ",39,M,,day 7 from symptom onse ,moderate,,,"['Figure 1. Transverse chest CT from a 39 year-old man, showing ground-glass opacities of bilateral lungs near the pleura (a and b) on day 1 from symptom onset, and increased bilateral ground-glass opacities and consolidation(c and d) on day 5  from symptom onset, and slightly absorbed ground-glass opacities (e and f) on day 7 from symptom onset after 7-day treatment.']"
2020.02.23.20026856-p17-115%3.png,Patient 23,1,"Zhejiang, China ",39,M,,day 5 from symptom onse ,moderate,,,"['Figure 1. Transverse chest CT from a 39 year-old man, showing ground-glass opacities of bilateral lungs near the pleura (a and b) on day 1 from symptom onset, and increased bilateral ground-glass opacities and consolidation(c and d) on day 5  from symptom onset, and slightly absorbed ground-glass opacities (e and f) on day 7 from symptom onset after 7-day treatment.']"
2020.02.23.20026856-p17-115%2.png,Patient 23,1,"Zhejiang, China ",39,M,,day 5  from symptom onse ,moderate,,,"['Figure 1. Transverse chest CT from a 39 year-old man, showing ground-glass opacities of bilateral lungs near the pleura (a and b) on day 1 from symptom onset, and increased bilateral ground-glass opacities and consolidation(c and d) on day 5  from symptom onset, and slightly absorbed ground-glass opacities (e and f) on day 7 from symptom onset after 7-day treatment.']"
2020.02.23.20026856-p17-115%1.png,Patient 23,1,"Zhejiang, China ",39,M,,day 1 from symptom onse ,moderate,,,"['Figure 1. Transverse chest CT from a 39 year-old man, showing ground-glass opacities of bilateral lungs near the pleura (a and b) on day 1 from symptom onset, and increased bilateral ground-glass opacities and consolidation(c and d) on day 5  from symptom onset, and slightly absorbed ground-glass opacities (e and f) on day 7 from symptom onset after 7-day treatment.']"
2020.02.23.20026856-p17-115%0.png,Patient 23,1,"Zhejiang, China ",39,M,,day 1 from symptom onse ,moderate,,,"['Figure 1. Transverse chest CT from a 39 year-old man, showing ground-glass opacities of bilateral lungs near the pleura (a and b) on day 1 from symptom onset, and increased bilateral ground-glass opacities and consolidation(c and d) on day 5  from symptom onset, and slightly absorbed ground-glass opacities (e and f) on day 7 from symptom onset after 7-day treatment.']"
Talaromyces-marneffei-infection-relapse-presenting-as-ost_2020_International-p1-12%3,Patient 216,1,N/A,N/A,N/A,,,severe,,10.1016/j.ijid.2020.02.037,Computed tomography of the lungs revealed mass lesions in bilateral upper lobe before anti-NTM treatment (a and b; January 2017) and remarkable absorption after 3-month anti-NTM treatment (c and d; April 2017).
Talaromyces-marneffei-infection-relapse-presenting-as-ost_2020_International-p1-12%2,Patient 216,1,N/A,N/A,N/A,,,severe,,10.1016/j.ijid.2020.02.037,Computed tomography of the lungs revealed mass lesions in bilateral upper lobe before anti-NTM treatment (a and b; January 2017) and remarkable absorption after 3-month anti-NTM treatment (c and d; April 2017).
Talaromyces-marneffei-infection-relapse-presenting-as-ost_2020_International-p1-12%1,Patient 216,1,N/A,N/A,N/A,,,severe,,10.1016/j.ijid.2020.02.037,Computed tomography of the lungs revealed mass lesions in bilateral upper lobe before anti-NTM treatment (a and b; January 2017) and remarkable absorption after 3-month anti-NTM treatment (c and d; April 2017).
Talaromyces-marneffei-infection-relapse-presenting-as-ost_2020_International-p1-12%0,Patient 216,1,N/A,N/A,N/A,,,severe,,10.1016/j.ijid.2020.02.037,Computed tomography of the lungs revealed mass lesions in bilateral upper lobe before anti-NTM treatment (a and b; January 2017) and remarkable absorption after 3-month anti-NTM treatment (c and d; April 2017).
Recurrence-of-positive-SARS-CoV-2-RNA-in-C_2020_International-Journal-of-Inf-p1-21%1,Patient 215,1,N/A,N/A,N/A,,,severe,,10.1016/j.ijid.2020.03.003 ,"ChestHRCTimageson23January2020,showingmultiplepatchygroundglassopacitiesinbilateralsubpleuralareas(redarrows).HRCT,high-resolutioncomputed tomography. "
Recurrence-of-positive-SARS-CoV-2-RNA-in-C_2020_International-Journal-of-Inf-p1-21%0,Patient 215,1,N/A,N/A,N/A,,,severe,,10.1016/j.ijid.2020.03.003 ,"ChestHRCTimageson23January2020,showingmultiplepatchygroundglassopacitiesinbilateralsubpleuralareas(redarrows).HRCT,high-resolutioncomputed tomography. "
PIIS0140673620303603%8,Patient 214,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3,
PIIS0140673620303603%7,Patient 213,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3,
PIIS0140673620303603%6,Patient 212,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3,
PIIS0140673620303603%5,Patient 211,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3,
PIIS0140673620303603%4,Patient 210,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3,
PIIS0140673620303603%3,Patient 209,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3,
PIIS0140673620303603%2,Patient 208,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3,
PIIS0140673620303603%1,Patient 207,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3 ,
PIIS0140673620303603%0,Patient 206,1,N/A,N/A,N/A,,,moderate,,10.1016/ S0140-6736(20)30360-3 ,
PIIS0140673620302117_2,Patient 205,1,N/A,N/A,N/A,,,severe,,10.1016/ S0140-6736(20)30211-7 ,"Case 3: chest CT obtained on Jan 1 (3A) showed mass shadows of high density in both lungs. Bright bronchogram is seen in the lung tissue area of the lesion, which is also called bronchoinflation sign. Chest CT on Jan 15 showed improved status (3B). "
PIIS0140673620302117_1,Patient 205,1,N/A,N/A,N/A,,,severe,,10.1016/ S0140-6736(20)30211-7 ,"Case 3: chest CT obtained on Jan 1 (3A) showed mass shadows of high density in both lungs. Bright bronchogram is seen in the lung tissue area of the lesion, which is also called bronchoinflation sign. Chest CT on Jan 15 showed improved status (3B). "
PIIS0140673620301549_2,Patient 204,1,N/A,N/A,N/A,,,severe,,10.1016/ S0140-6736(20)30154-9,"Figure 2: Representative images of the thoracic CT scans showing multifocal ground-glass changes in the lungs of patient 1 (A), patient 2 (B), patient 3 (C), and patient 5 (D) "
PIIS0140673620301549_1,Patient 203,1,N/A,N/A,N/A,,,severe,,10.1016/ S0140-6736(20)30154-9,"Figure 2: Representative images of the thoracic CT scans showing multifocal ground-glass changes in the lungs of patient 1 (A), patient 2 (B), patient 3 (C), and patient 5 (D) "
PIIS0140673620301549_0%1,Patient 202,1,N/A,N/A,N/A,,,severe,,10.1016/ S0140-6736(20)30154-9 ,"Figure 2: Representative images of the thoracic CT scans showing multifocal ground-glass changes in the lungs of patient 1 (A), patient 2 (B), patient 3 (C), and patient 5 (D) "
PIIS0140673620301549_0%0,Patient 201,1,N/A,N/A,N/A,,,severe,,10.1016/ S0140-6736(20)30154-9 ,"Figure 2: Representative images of the thoracic CT scans showing multifocal ground-glass changes in the lungs of patient 1 (A), patient 2 (B), patient 3 (C), and patient 5 (D) "
Ni2020_Article_CombinationOfWesternMedicineAn-p4-13%1.png,Patient 200,1,N/A,N/A,N/A,,,moderate,,10.1007/s11684-020-0757-x,"Chest CT images of case 3. (A) CT imaging obtained from case 3 on January 28, 2020 shows ground glass opacity in the left lung on illness day 3. (B) Image taken on February 7, 2020 shows the absorption of ground glass opacity after SHL treatment from January 28. "
Ni2020_Article_CombinationOfWesternMedicineAn-p4-13%0.png,Patient 200,1,N/A,N/A,N/A,,,moderate,,10.1007/s11684-020-0757-x,"Chest CT images of case 3. (A) CT imaging obtained from case 3 on January 28, 2020 shows ground glass opacity in the left lung on illness day 3. (B) Image taken on February 7, 2020 shows the absorption of ground glass opacity after SHL treatment from January 28. "
Ni2020_Article_CombinationOfWesternMedicineAn-p3-10%1,Patient 199,1,N/A,N/A,N/A,,,moderate,,10.1007/s11684-020-0757-x ,"Chest CT images of case 2. (A) CT imaging obtained from case 2 on January 28, 2020 shows consolidation shadow in the left lung on illness day 3. (B) Image taken on February 6, 2020 shows the absorption of consolidation shadow after SHL treatment from January 28. "
Ni2020_Article_CombinationOfWesternMedicineAn-p3-10%0,Patient 199,1,N/A,N/A,N/A,,,moderate,,10.1007/s11684-020-0757-x ,"Chest CT images of case 2. (A) CT imaging obtained from case 2 on January 28, 2020 shows consolidation shadow in the left lung on illness day 3. (B) Image taken on February 6, 2020 shows the absorption of consolidation shadow after SHL treatment from January 28. "
med-9780198814924-chapter-17-p10-515,Patient 181,1,N/A,46,M ,,4,severe,,10.1093/med/9780198814924.003.0017 ,
kjr-21-e25-p1-8,Patient 197,1,N/A,40,F,,,moderate,,10.3348/kjr.2020.0112 ,40-year-old female patient with Coronavirus disease 2019 pneumonia.
kjr-21-e25-p1-6,Patient 197,1,N/A,40,F,,,moderate,,10.3348/kjr.2020.0112 ,40-year-old female patient with Coronavirus disease 2019 pneumonia.
kjr-21-e25-p1-14,Patient 197,1,N/A,40,F,,,moderate,,10.3348/kjr.2020.0112,40-year-old female patient with Coronavirus disease 2019 pneumonia.
kjr-21-e25-p1-12,Patient 197,1,N/A,40,F,,,moderate,,10.3348/kjr.2020.0112,40-year-old female patient with Coronavirus disease 2019 pneumonia.
kjr-21-e25-p1-10,Patient 197,1,N/A,40,F,,,moderate,,10.3348/kjr.2020.0112,40-year-old female patient with Coronavirus disease 2019 pneumonia.
kjr-21-e24-p5-31,Patient 196,1,N/A,N/A,N/A,,,severe,,10.3348/kjr.2020.0132,"Representative CT images (A, B) of COVID-19 pneumonia manifesting as radiograph-negative multiple patchy to nodular mixed ground-glass opacities and consolidations. A. Axial chest CT image shows ill-defined mixed ground-glass opacities and consolidative lesions with patchy and elongated shape (arrows) touching pleura in superior segment of right lower lobe. B. Axial chest CT image shows ill- defined part-solid nodules (arrows; mixed ground-glass opacities and solid nodules) along bronchovascular bundles in posterior segment of right upper lobe. "
kjr-21-e24-p5-29,Patient 195,1,N/A,N/A,N/A,,,severe,,10.3348/kjr.2020.0132,"Representative CT images (A, B) of COVID-19 pneumonia manifesting as radiograph-negative multiple patchy to nodular mixed ground-glass opacities and consolidations. A. Axial chest CT image shows ill-defined mixed ground-glass opacities and consolidative lesions with patchy and elongated shape (arrows) touching pleura in superior segment of right lower lobe. B. Axial chest CT image shows ill- defined part-solid nodules (arrows; mixed ground-glass opacities and solid nodules) along bronchovascular bundles in posterior segment of right upper lobe. "
kjr-21-e24-p3-16,Patient 194,1,N/A,N/A,N/A,,,severe,,10.3348/kjr.2020.0132 ,Baseline axial and coronal chest CT images show confluent pure ground-glass opacities involving both lungs. Most of confluent and patchy ground-glass opacities about pleura and fissure in peripheral lung. A few calcified granulomas are incidentally noted in left upper lobe. 
kjr-21-e24-p2-8,Patient 193,1,N/A,N/A,N/A,,,severe,,10.3348/kjr.2020.0132 ,"confluent lesions are mainly distributed in peripheral lung along bronchovascular bundles. Most of lesions spare juxtapleural area, and minor proportion of lesions touch pleura. Lesions contain multiple air-bronchograms, and air-bronchogram in superior segment of right lower lobe is distorted (arrows) "
impact_of_covid19_infection_on_pregnancy_outcomes_and_the_risk_of_maternaltoneonatal_intrapartum_transmission_of_covid19_during_natural_birth-p8-41%5,Patient 192,1,N/A,33,F ,,,pregnant,pregnancy,10.1017/ice.2020.84 ,
impact_of_covid19_infection_on_pregnancy_outcomes_and_the_risk_of_maternaltoneonatal_intrapartum_transmission_of_covid19_during_natural_birth-p8-41%3,Patient 191,1,N/A,27,F ,,,pregnant,pregnancy,10.1017/ice.2020.84 ,
impact_of_covid19_infection_on_pregnancy_outcomes_and_the_risk_of_maternaltoneonatal_intrapartum_transmission_of_covid19_during_natural_birth-p8-41%1,Patient 190,1,N/A,28,F ,,,pregnant,pregnancy,10.1017/ice.2020.84 ,
ehaa254-p0-63%3,Patient 189,1,N/A,75,F ,,10,moderate,,10.1093/eurheartj/ehaa254 ,"Lower-limb compression ultrasonography was negative. Based on these findings, treatment with low molecular weight heparin, lopinavir/ritonavir, and hydroxychloroquine was started. "
ehaa254-p0-63%2,Patient 189,1,N/A,75,F ,,10,moderate,,10.1093/eurheartj/ehaa254 ,"Lower-limb compression ultrasonography was negative. Based on these findings, treatment with low molecular weight heparin, lopinavir/ritonavir, and hydroxychloroquine was started. "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%9,Patient 187,1,N/A,33,M,,10,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%8,Patient 187,1,N/A,33,M,,6,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%7,Patient 186,1,N/A,31,M,,6,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%6,Patient 186,1,N/A,31,M,,4,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%5,Patient 185,1,N/A,59,F ,,8,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%4,Patient 185,1,N/A,59,F ,,6,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%3,Patient 184,1,N/A,45,F ,,7,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%2,Patient 184,1,N/A,45,F ,,5,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%11,Patient 188,1,N/A,39,M,,5,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%10,Patient 188,1,N/A,39,M,,2,severe,,10.1016/j.ijid.2020.02.050,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%1,Patient 183,1,N/A,62,F ,,7,severe,,10.1016/j.ijid.2020.02.050 ,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
Comparison-of-different-samples-for-2019-novel-cor_2020_International-Journa-p2-21%0,Patient 183,1,N/A,62,F ,,5,severe,,10.1016/j.ijid.2020.02.050 ,"CTscansofthe2019-nCoVnucleicacid–detectedpositivepatients.Increasingandmultifocalground-glasschangeswerevisible.(A)Patient1,January30,2020(hospital day 2, illness day 5, A-1); February 1, 2020 (hospital day 4, illness day 7, A-2). (B) Patient 2, January 30, 2020 (hospital day 2, illness day 5, B-1); February 1, 2020 (hospital day 4, illness day 7, B-2). (C) Patient 3, January 30, 2020 (hospital day 1, illness day 6, C-1); February 1, 2020 (hospital day 3, illness day 8, C-2). (D) Suspected case 1, January 31, 2020 (hospital day 1, illness day 4, D-1); February 1, 2020 (hospital day 6, illness day 9, D-2). (E) Suspected case 3, February 1, 2020 (hospital day 1, illness day 6, E-1); February 5, 2020 (hospital day 5, illness day 10, E-2). (F) Suspected case 4, January 31, 2020 (hospital day 1, illness day 2, F-1); February 1, 2020 (hospital day 4, illness day 5, F-2). "
bmj.m606.full-p4-22%7,Patient 182,1,N/A,32,M ,,7,severe,,10.1136/bmj.m606,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
bmj.m606.full-p4-22%6,Patient 182,1,N/A,32,M ,,7,severe,,10.1136/bmj.m606,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
bmj.m606.full-p4-22%5,Patient 182,1,N/A,32,M ,,7,severe,,10.1136/bmj.m606,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
bmj.m606.full-p4-22%4,Patient 182,1,N/A,32,M ,,7,severe,,10.1136/bmj.m606,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
bmj.m606.full-p4-22%3,Patient 182,1,N/A,32,M ,,1,severe,,10.1136/bmj.m606,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
bmj.m606.full-p4-22%2,Patient 182,1,N/A,32,M ,,1,severe,,10.1136/bmj.m606,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
bmj.m606.full-p4-22%1,Patient 182,1,N/A,32,M ,,1,severe,,10.1136/bmj.m606 ,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
bmj.m606.full-p4-22%0,Patient 182,1,N/A,32,M ,,1,severe,,10.1136/bmj.m606 ,"Transverse chest computed tomograms from a 32 year old man, showing ground glass opacity and consolidation of lower lobe of right lung near the pleura on day 1 after symptom onset (top panel), and bilateral ground glass opacity and consolidation on day 7 after symptom onset (bottom panel) "
2020.03.30.20047985-p9-56%3,Patient 178,1,N/A,N/A,N/A,,,severe,,,"A 61-year-old man from Lodi (endemic city in Lombardy) attended to the emergency department of San Raffaele Hospital in Milan for fever, caught and dyspnoea. Epidemiologic, clinical evaluation and lab tests resulted highly suspicious for SARS-CoV2 infection. Nasopharyngeal swab was collected, and chest CT was immediately performed. CT showed peripheral opacity (A) with ground- glass opacities and crazy-paving pattern involving mainly the upper left lobe (B-D) and the lower right lobe (D-E), with typical posterior involvement. CT findings were highly suggestive for SARS- CoV2 pneumonia. 3D volume rendering CT reconstruction captures the overall pulmonary involvement (F). Results from the first swab (available 24 hours later) resulted negative. Another swab was taken after 3 days, resulting positive. "
2020.03.30.20047985-p9-56%2,Patient 178,1,N/A,N/A,N/A,,,severe,,,"A 61-year-old man from Lodi (endemic city in Lombardy) attended to the emergency department of San Raffaele Hospital in Milan for fever, caught and dyspnoea. Epidemiologic, clinical evaluation and lab tests resulted highly suspicious for SARS-CoV2 infection. Nasopharyngeal swab was collected, and chest CT was immediately performed. CT showed peripheral opacity (A) with ground- glass opacities and crazy-paving pattern involving mainly the upper left lobe (B-D) and the lower right lobe (D-E), with typical posterior involvement. CT findings were highly suggestive for SARS- CoV2 pneumonia. 3D volume rendering CT reconstruction captures the overall pulmonary involvement (F). Results from the first swab (available 24 hours later) resulted negative. Another swab was taken after 3 days, resulting positive. "
2020.03.30.20047985-p9-56%1,Patient 178,1,N/A,N/A,N/A,,,severe,,,"A 61-year-old man from Lodi (endemic city in Lombardy) attended to the emergency department of San Raffaele Hospital in Milan for fever, caught and dyspnoea. Epidemiologic, clinical evaluation and lab tests resulted highly suspicious for SARS-CoV2 infection. Nasopharyngeal swab was collected, and chest CT was immediately performed. CT showed peripheral opacity (A) with ground- glass opacities and crazy-paving pattern involving mainly the upper left lobe (B-D) and the lower right lobe (D-E), with typical posterior involvement. CT findings were highly suggestive for SARS- CoV2 pneumonia. 3D volume rendering CT reconstruction captures the overall pulmonary involvement (F). Results from the first swab (available 24 hours later) resulted negative. Another swab was taken after 3 days, resulting positive. "
2020.03.30.20047985-p9-56%0,Patient 178,1,N/A,N/A,N/A,,,severe,,,"A 61-year-old man from Lodi (endemic city in Lombardy) attended to the emergency department of San Raffaele Hospital in Milan for fever, caught and dyspnoea. Epidemiologic, clinical evaluation and lab tests resulted highly suspicious for SARS-CoV2 infection. Nasopharyngeal swab was collected, and chest CT was immediately performed. CT showed peripheral opacity (A) with ground- glass opacities and crazy-paving pattern involving mainly the upper left lobe (B-D) and the lower right lobe (D-E), with typical posterior involvement. CT findings were highly suggestive for SARS- CoV2 pneumonia. 3D volume rendering CT reconstruction captures the overall pulmonary involvement (F). Results from the first swab (available 24 hours later) resulted negative. Another swab was taken after 3 days, resulting positive. "
2020.03.26.20041426-p11-133,Patient 177,1,N/A,N/A,N/A,,,severe,,,"Fig3. Chest CT images of a 62-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 11,2020, revealed the lesions increased rapidly, and the patient died on February 16,2020. "
2020.03.26.20041426-p11-132,Patient 177,1,N/A,N/A,N/A,,,severe,,,"Fig3. Chest CT images of a 62-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 11,2020, revealed the lesions increased rapidly, and the patient died on February 16,2020. "
2020.03.26.20041426-p11-131,Patient 177,1,N/A,N/A,N/A,,,severe,,,"Fig3. Chest CT images of a 62-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 11,2020, revealed the lesions increased rapidly, and the patient died on February 16,2020. "
2020.03.26.20041426-p11-130,Patient 177,1,N/A,N/A,N/A,,,severe,,,"Fig3. Chest CT images of a 62-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 11,2020, revealed the lesions increased rapidly, and the patient died on February 16,2020. "
2020.03.26.20041426-p11-128,Patient 177,1,N/A,N/A,N/A,,,severe,,,"Fig3. Chest CT images of a 62-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 11,2020, revealed the lesions increased rapidly, and the patient died on February 16,2020. "
2020.03.26.20041426-p11-127,Patient 177,1,N/A,N/A,N/A,,,severe,,,"Fig3. Chest CT images of a 62-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 11,2020, revealed the lesions increased rapidly, and the patient died on February 16,2020. "
2020.03.26.20041426-p11-126,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.26.20041426-p11-125,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.26.20041426-p11-124,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.26.20041426-p11-123,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.26.20041426-p11-122,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.26.20041426-p11-121,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.26.20041426-p11-120,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.26.20041426-p11-119,Patient 176,1,N/A,N/A,N/A,,,severe,,,"Fig2. Chest CT images of a 26-year-old patient with COVID-19. a Chest CT images obtained on February 2, 2020, showed ground glass opacity in both lungs on day 5 after symptom onset. b Images taken on February 12,2020, indicated the lesions increased obviously. C Images taken on February 19, 2020.revealed bilateral ground glass opacity absorbed dramatically, and the patient discharged from hospital and return to the local hospital. "
2020.03.25.20043166-p17-81,Patient 175,1,N/A,N/A,N/A,,,moderate,,,CT scan of the four cases 
2020.03.25.20043166-p17-80,Patient 174,1,N/A,N/A,N/A,,,moderate,,,CT scan of the four cases 
2020.03.25.20043166-p17-79,Patient 173,1,N/A,N/A,N/A,,,moderate,,,CT scan of the four cases 
2020.03.25.20043166-p17-78,Patient 172,1,N/A,N/A,N/A,,,moderate,,,CT scan of the four cases 
2020.03.25.20037721-p27-182.png,Patient 171,1,N/A,N/A,N/A,,,severe,,,"Figure S1. Representative dynamic changes in chest computer tomography (CT) scans from two patients with COVID-19. A1–A3, CT images of a 70- year-old male patient, who progressed from the non-severe to critical disease group, and died. A1 (day 1), A2 (day 4), A3 (day 9): below the pleura are scattered shadows of frosted glass, large sheet diffuse paving stones in both lungs, and extensive consolidation of both lungs with thickening of interlobular stroma repetitively. B1–B3, CT images of a 44-year-old female patient, who progressed from the critical to non-severe disease group. B1 (day 3) exhibiting extensive consolidation of both lungs; B2 (day 9) exhibiting frosted hyaline change and paving stone signs. B3 (day 20) showing significant resolution of ground-glass opacities and subpleural cord changes. "
2020.03.25.20037721-p27-181.png,Patient 171,1,N/A,N/A,N/A,,,severe,,,"Figure S1. Representative dynamic changes in chest computer tomography (CT) scans from two patients with COVID-19. A1–A3, CT images of a 70- year-old male patient, who progressed from the non-severe to critical disease group, and died. A1 (day 1), A2 (day 4), A3 (day 9): below the pleura are scattered shadows of frosted glass, large sheet diffuse paving stones in both lungs, and extensive consolidation of both lungs with thickening of interlobular stroma repetitively. B1–B3, CT images of a 44-year-old female patient, who progressed from the critical to non-severe disease group. B1 (day 3) exhibiting extensive consolidation of both lungs; B2 (day 9) exhibiting frosted hyaline change and paving stone signs. B3 (day 20) showing significant resolution of ground-glass opacities and subpleural cord changes. "
2020.03.25.20037721-p27-174.png,Patient 170,1,N/A,N/A,N/A,,,severe,,,"Figure S1. Representative dynamic changes in chest computer tomography (CT) scans from two patients with COVID-19. A1–A3, CT images of a 70- year-old male patient, who progressed from the non-severe to critical disease group, and died. A1 (day 1), A2 (day 4), A3 (day 9): below the pleura are scattered shadows of frosted glass, large sheet diffuse paving stones in both lungs, and extensive consolidation of both lungs with thickening of interlobular stroma repetitively. B1–B3, CT images of a 44-year-old female patient, who progressed from the critical to non-severe disease group. B1 (day 3) exhibiting extensive consolidation of both lungs; B2 (day 9) exhibiting frosted hyaline change and paving stone signs. B3 (day 20) showing significant resolution of ground-glass opacities and subpleural cord changes. "
2020.03.25.20037721-p27-173.png,Patient 170,1,N/A,N/A,N/A,,,severe,,,"Figure S1. Representative dynamic changes in chest computer tomography (CT) scans from two patients with COVID-19. A1–A3, CT images of a 70- year-old male patient, who progressed from the non-severe to critical disease group, and died. A1 (day 1), A2 (day 4), A3 (day 9): below the pleura are scattered shadows of frosted glass, large sheet diffuse paving stones in both lungs, and extensive consolidation of both lungs with thickening of interlobular stroma repetitively. B1–B3, CT images of a 44-year-old female patient, who progressed from the critical to non-severe disease group. B1 (day 3) exhibiting extensive consolidation of both lungs; B2 (day 9) exhibiting frosted hyaline change and paving stone signs. B3 (day 20) showing significant resolution of ground-glass opacities and subpleural cord changes. "
2020.03.25.20037721-p27-172.png,Patient 170,1,N/A,N/A,N/A,,,severe,,,"Figure S1. Representative dynamic changes in chest computer tomography (CT) scans from two patients with COVID-19. A1–A3, CT images of a 70- year-old male patient, who progressed from the non-severe to critical disease group, and died. A1 (day 1), A2 (day 4), A3 (day 9): below the pleura are scattered shadows of frosted glass, large sheet diffuse paving stones in both lungs, and extensive consolidation of both lungs with thickening of interlobular stroma repetitively. B1–B3, CT images of a 44-year-old female patient, who progressed from the critical to non-severe disease group. B1 (day 3) exhibiting extensive consolidation of both lungs; B2 (day 9) exhibiting frosted hyaline change and paving stone signs. B3 (day 20) showing significant resolution of ground-glass opacities and subpleural cord changes. "
2020.03.25.20037721-p27-165.png,Patient 171,1,N/A,N/A,N/A,,,severe,,,"Figure S1. Representative dynamic changes in chest computer tomography (CT) scans from two patients with COVID-19. A1–A3, CT images of a 70- year-old male patient, who progressed from the non-severe to critical disease group, and died. A1 (day 1), A2 (day 4), A3 (day 9): below the pleura are scattered shadows of frosted glass, large sheet diffuse paving stones in both lungs, and extensive consolidation of both lungs with thickening of interlobular stroma repetitively. B1–B3, CT images of a 44-year-old female patient, who progressed from the critical to non-severe disease group. B1 (day 3) exhibiting extensive consolidation of both lungs; B2 (day 9) exhibiting frosted hyaline change and paving stone signs. B3 (day 20) showing significant resolution of ground-glass opacities and subpleural cord changes. "
2020.03.22.20040782-p25-1546.png,Patient 167,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity ']"
2020.03.22.20040782-p25-1545.png,Patient 166,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity ']"
2020.03.22.20040782-p25-1544.png,Patient 165,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity ']"
2020.03.22.20040782-p25-1543.png,Patient 164,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity ']"
2020.03.22.20040782-p25-1542.png,Patient 163,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity ']"
2020.03.22.20040782-p25-1541.png,Patient 162,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity ']"
2020.03.22.20040782-p24-1533-8.png,Patient 161,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity H, GGO with unilateral and subpleural distribution']"
2020.03.22.20040782-p24-1533-7.png,Patient 160,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity G, GGO with air bronchogram and subpleural distribution']"
2020.03.22.20040782-p24-1533-6.png,Patient 159,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity F, GGO with consolidation']"
2020.03.22.20040782-p24-1533-5.png,Patient 158,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity E, GGO with crazy-paving pattern and air bronchogram']"
2020.03.22.20040782-p24-1533-4.png,Patient 157,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity D, GGO with bilateral and subpleural distribution']"
2020.03.22.20040782-p24-1533-3.png,Patient 156,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity C, GGO']"
2020.03.22.20040782-p24-1533-2.png,Patient 155,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity B, crazy-paving pattern with subpleural and bilateral lower pulmonary distribution']"
2020.03.22.20040782-p24-1533-1.png,Patient 154,1,N/A,N/A,N/A,,,severe,,,"['Figure 1 Various chest CT imaging features of COVID-19 GGO, ground glass opacity A, GGO with bilateral and subpleural distribution']"
2020.03.12.20034686-p17-91-2.png,Patient 169,1,N/A,N/A,N/A,,,severe,,,Fig 2. Typical Features of CT Images of Paediatric Patients with COVID-19.
2020.03.12.20034686-p17-91-1.png,Patient 168,1,N/A,N/A,N/A,,,severe,,,Fig 2. Typical Features of CT Images of Paediatric Patients with COVID-19.
2020.03.11.20033159-p12-45%5.png,Patient 119,1,N/A,N/A,N/A,,,moderate,,10.1101/2020.03.11.20033159,['Figure 1. Transverse Chest Computed Tomographic Images. No change in CT imaging was observed during patient's hospitalization (3B).']
2020.03.11.20033159-p12-45%4.png,Patient 119,1,N/A,N/A,N/A,,,moderate,,10.1101/2020.03.11.20033159,['Figure 1. Transverse Chest Computed Tomographic Images. There was no obvious abnormality in bilateral lung fields of case 3 on admission (3A).']
2020.03.09.20033118-p20-93%3.png,Patient 114,1,N/A,28,M,,,moderate,,10.1101/2020.03.09.20033118,"['Figure 1: Transverse thin-section CT scans in medical staffs infected with COVID-19 pneumonia. (D) 28-year-old man: bilateral and linear consolidations in the right and left upper lobes (arrow), regarded as chronic lung lesion with lack of changes on serial CT examinations.']"
2020.03.09.20033118-p20-93%2.png,Patient 113,1,N/A,55,M,,,moderate,,10.1101/2020.03.09.20033118,"['Figure 1: Transverse thin-section CT scans in medical staffs infected with COVID-19 pneumonia. (C) 55-year-old man: bilateral, peripheral ground-glass opacity mixed consolidation pattern.']"
2020.03.09.20033118-p20-93%1.png,Patient 112,1,N/A,41,F,,,moderate,,10.1101/2020.03.09.20033118,['Figure 1: Transverse thin-section CT scans in medical staffs infected with COVID-19 pneumonia. (B) 41-year-old woman: focal ground-glass opacity associated with smooth interlobular and intralobular septal thickening (crazy-paving pattern).']
2020.03.09.20033118-p20-93%0.png,Patient 111,1,N/A,27,F,,,moderate,,10.1101/2020.03.09.20033118,"['Figure 1: Transverse thin-section CT scans in medical staffs infected with COVID-19 pneumonia. (A) 27-year-old woman: bilateral, peripheral ground-glass opacity in the right lower lobe and left upper lobe (arrow).']"
2020.03.04.20031047-p12-81%3.png,Patient 98,1,N/A,N/A,N/A,,,severe,COVID-19 with rounded GGO in bilateral lungs,10.1101/2020.03.04.20031047,"['FIGURE 1, Typical imaging for heart failure and COVID-19 pneumonia. D, COVID-19 with rounded GGO in bilateral lungs, partial consolidation was found inside.']"
2020.03.04.20031047-p12-81%2.png,Patient 97,1,N/A,N/A,N/A,,,severe,single rounded subpleural GGO in left lung.,10.1101/2020.03.04.20031047,"['FIGURE 1, Typical imaging for heart failure and COVID-19 pneumonia. C, COVID-19 with single rounded subpleural GGO in left lung.']"
2020.03.04.20031047-p12-81%1.png,Patient 96,1,N/A,N/A,N/A,,,severe,Heart failure with bilateral diffuse GGO disease,10.1101/2020.03.04.20031047,"['FIGURE 1, Typical imaging for heart failure and COVID-19 pneumonia. B, Heart failure with bilateral diffuse GGO disease. Peribronchovascular thickening, clear interlobular septal thickening even fissural thickening were found without subpleural effusion. ']"
2020.03.04.20031047-p12-81%0.png,Patient 95,1,N/A,N/A,N/A,,,severe,Heart failure with bilateral diffuse disease,10.1101/2020.03.04.20031047,"['FIGURE 1, Typical imaging for heart failure and COVID-19 pneumonia. A, Heart failure with bilateral diffuse disease. The disease presented with a gradient distribution and partial GGO and consolidation inside, accompanied with subpleural effusion. Peribronchovascular and septal thickening were also found. ']"
2020.02.26.20026989-p34-114_2%1.png,Patient 61,1,N/A,N/A,N/A,,,severe,,10.1101/2020.02.26.20026989,"['Figure 3. The relationship of pulmonary inflammation and CRSL characteristics after COVID-19 infected.  A. Computed tomography of the chest of patients with COVID-19. According to the patchy or ground glass shadows in the chest CT images, the patients were divided into < 5 0 % and ≥ 5 0 % groups.']"
2020.02.26.20026989-p34-114_2%0.png,Patient 60,1,N/A,N/A,N/A,,,severe,,10.1101/2020.02.26.20026989,"['Figure 3. The relationship of pulmonary inflammation and CRSL characteristics after COVID-19 infected.  A. Computed tomography of the chest of patients with COVID-19. According to the patchy or ground glass shadows in the chest CT images, the patients were divided into < 5 0 % and ≥ 5 0 % groups.']"
2020.02.26.20026989-p34-114_1%1.png,Patient 59,1,N/A,N/A,N/A,,,severe,,10.1101/2020.02.26.20026989,"['Figure 3. The relationship of pulmonary inflammation and CRSL characteristics after COVID-19 infected.  A. Computed tomography of the chest of patients with COVID-19. According to the patchy or ground glass shadows in the chest CT images, the patients were divided into < 5 0 % and ≥ 5 0 % groups.']"
2020.02.26.20026989-p34-114_1%0.png,Patient 58,1,N/A,N/A,N/A,,,severe,,10.1101/2020.02.26.20026989,"['Figure 3. The relationship of pulmonary inflammation and CRSL characteristics after COVID-19 infected.  A. Computed tomography of the chest of patients with COVID-19. According to the patchy or ground glass shadows in the chest CT images, the patients were divided into < 5 0 % and ≥ 5 0 % groups.']"
2019-novel-Coronavirus-severe-adult-respiratory-dist_2020_International-Jour-p3-91,Patient 180 ,1,N/A,65,F ,,3,severe,,10.1016/j.ijid.2020.02.043,(a) Follow-up CT after 3 days in a 65 years old woman shows increase size and density of the lesions 
2019-novel-Coronavirus-severe-adult-respiratory-dist_2020_International-Jour-p3-89%1,Patient 179,1,N/A,65,F ,,0,moderate,,10.1016/j.ijid.2020.02.043 ,"(a) Baseline chest CT shows tubular size increase of segmental vessel with normally ventilated adjacent lung parenchyma, (b) where after 3 days there is a ground-glass opacities. "
2019-novel-Coronavirus-severe-adult-respiratory-dist_2020_International-Jour-p3-89%0,Patient 179,1,N/A,65,F ,,3,moderate,,10.1016/j.ijid.2020.02.043 ,"(a) Baseline chest CT shows tubular size increase of segmental vessel with normally ventilated adjacent lung parenchyma, (b) where after 3 days there is a ground-glass opacities. "
997.png,medpix_patient_50,0,,N/A,N/A,,,,,,
996.png,medpix_patient_50,0,,N/A,N/A,,,,,,
969.png,medpix_patient_21,0,,N/A,N/A,,,,,,
957.png,medpix_patient_19,0,,N/A,N/A,,,,,,
956.png,medpix_patient_19,0,,N/A,N/A,,,,,,
921.png,medpix_patient_11,0,,N/A,N/A,,,,,,
91%1.jpg,crawled_patient_91,0,,N/A,N/A,,,,,,
91%0.jpg,crawled_patient_91,0,,N/A,N/A,,,,,,
90.jpg,crawled_patient_90,0,,N/A,N/A,,,,,,
9.jpg,crawled_patient_9,0,,N/A,N/A,,,,,,
890.png,medpix_patient_66,0,,N/A,N/A,,,,,,
89%3.jpg,crawled_patient_89,0,,N/A,N/A,,,,,,
89%2.jpg,crawled_patient_89,0,,N/A,N/A,,,,,,
889.png,medpix_patient_66,0,,N/A,N/A,,,,,,
887.png,medpix_patient_66,0,,N/A,N/A,,,,,,
88.jpg,crawled_patient_88,0,,N/A,N/A,,,,,,
86.jpg,crawled_patient_86,0,,N/A,N/A,,,,,,
85%1.jpg,crawled_patient_85,0,,N/A,N/A,,,,,,
85%0.jpg,crawled_patient_85,0,,N/A,N/A,,,,,,
849.png,medpix_patient_5,0,,N/A,N/A,,,,,,
848.png,medpix_patient_5,0,,N/A,N/A,,,,,,
84%3.jpg,crawled_patient_84,0,,N/A,N/A,,,,,,
84%2.jpg,crawled_patient_84,0,,N/A,N/A,,,,,,
84%1.jpg,crawled_patient_84,0,,N/A,N/A,,,,,,
84%0.jpg,crawled_patient_84,0,,N/A,N/A,,,,,,
83%3.jpg,crawled_patient_83,0,,N/A,N/A,,,,,,
83%2.jpg,crawled_patient_83,0,,N/A,N/A,,,,,,
83%1.jpg,crawled_patient_83,0,,N/A,N/A,,,,,,
83%0.jpg,crawled_patient_83,0,,N/A,N/A,,,,,,
82.png,medpix_patient_81,0,,N/A,N/A,,,,,,
82%3.jpg,crawled_patient_82,0,,N/A,N/A,,,,,,
82%2.jpg,crawled_patient_82,0,,N/A,N/A,,,,,,
82%1.jpg,crawled_patient_82,0,,N/A,N/A,,,,,,
82%0.jpg,crawled_patient_82,0,,N/A,N/A,,,,,,
81.png,medpix_patient_81,0,,N/A,N/A,,,,,,
81%3.jpg,crawled_patient_81,0,,N/A,N/A,,,,,,
81%2.jpg,crawled_patient_81,0,,N/A,N/A,,,,,,
81%1.jpg,crawled_patient_81,0,,N/A,N/A,,,,,,
81%0.jpg,crawled_patient_81,0,,N/A,N/A,,,,,,
80%1.jpg,crawled_patient_80,0,,N/A,N/A,,,,,,
80%0.jpg,crawled_patient_80,0,,N/A,N/A,,,,,,
8.jpg,crawled_patient_8,0,,N/A,N/A,,,,,,
79.jpg,crawled_patient_79,0,,N/A,N/A,,,,,,
782.png,medpix_patient_28,0,,N/A,N/A,,,,,,
781.png,medpix_patient_28,0,,N/A,N/A,,,,,,
78.jpg,crawled_patient_78,0,,N/A,N/A,,,,,,
77.jpg,crawled_patient_77,0,,N/A,N/A,,,,,,
76%2.jpg,crawled_patient_76,0,,N/A,N/A,,,,,,
76%1.jpg,crawled_patient_76,0,,N/A,N/A,,,,,,
76%0.jpg,crawled_patient_76,0,,N/A,N/A,,,,,,
754.png,medpix_patient_43,0,,N/A,N/A,,,,,,
753.png,medpix_patient_43,0,,N/A,N/A,,,,,,
75%1.jpg,crawled_patient_75,0,,N/A,N/A,,,,,,
75%0.jpg,crawled_patient_75,0,,N/A,N/A,,,,,,
74.jpg,crawled_patient_74,0,,N/A,N/A,,,,,,
73.jpg,crawled_patient_73,0,,N/A,N/A,,,,,,
72.jpg,crawled_patient_72,0,,N/A,N/A,,,,,,
71%1.jpg,crawled_patient_71,0,,N/A,N/A,,,,,,
71%0.jpg,crawled_patient_71,0,,N/A,N/A,,,,,,
709.png,medpix_patient_27,0,,N/A,N/A,,,,,,
706.png,medpix_patient_44,0,,N/A,N/A,,,,,,
705.png,medpix_patient_44,0,,N/A,N/A,,,,,,
704.png,medpix_patient_44,0,,N/A,N/A,,,,,,
70%1.jpg,crawled_patient_70,0,,N/A,N/A,,,,,,
70%0.jpg,crawled_patient_70,0,,N/A,N/A,,,,,,
7.jpg,crawled_patient_7,0,,N/A,N/A,,,,,,
69%1.jpg,crawled_patient_69,0,,N/A,N/A,,,,,,
69%0.jpg,crawled_patient_69,0,,N/A,N/A,,,,,,
68.jpg,crawled_patient_68,0,,N/A,N/A,,,,,,
673.png,medpix_patient_47,0,,N/A,N/A,,,,,,
672.png,medpix_patient_47,0,,N/A,N/A,,,,,,
67%2.jpg,crawled_patient_67,0,,N/A,N/A,,,,,,
67%1.jpg,crawled_patient_67,0,,N/A,N/A,,,,,,
67%0.jpg,crawled_patient_67,0,,N/A,N/A,,,,,,
663.png,medpix_patient_57,0,,N/A,N/A,,,,,,
662.png,medpix_patient_57,0,,N/A,N/A,,,,,,
661.png,medpix_patient_57,0,,N/A,N/A,,,,,,
660.png,medpix_patient_57,0,,N/A,N/A,,,,,,
66.jpg,crawled_patient_66,0,,N/A,N/A,,,,,,
658.png,medpix_patient_57,0,,N/A,N/A,,,,,,
65%4.jpg,crawled_patient_65,0,,N/A,N/A,,,,,,
65%3.jpg,crawled_patient_65,0,,N/A,N/A,,,,,,
65%2.jpg,crawled_patient_65,0,,N/A,N/A,,,,,,
65%1.jpg,crawled_patient_65,0,,N/A,N/A,,,,,,
65%0.jpg,crawled_patient_65,0,,N/A,N/A,,,,,,
64.jpg,crawled_patient_64,0,,N/A,N/A,,,,,,
63%7.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
63%6.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
63%5.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
63%4.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
63%3.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
63%2.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
63%1.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
63%0.jpg,crawled_patient_63,0,,N/A,N/A,,,,,,
62.jpg,crawled_patient_62,0,,N/A,N/A,,,,,,
60.jpg,crawled_patient_60,0,,N/A,N/A,,,,,,
6%3.jpg,crawled_patient_6,0,,N/A,N/A,,,,,,
6%2.jpg,crawled_patient_6,0,,N/A,N/A,,,,,,
6%1.jpg,crawled_patient_6,0,,N/A,N/A,,,,,,
6%0.jpg,crawled_patient_6,0,,N/A,N/A,,,,,,
592.png,medpix_patient_14,0,,N/A,N/A,,,,,,
591.png,medpix_patient_14,0,,N/A,N/A,,,,,,
590.png,medpix_patient_14,0,,N/A,N/A,,,,,,
59.png,medpix_patient_61,0,,N/A,N/A,,,,,,
59%0.jpg,crawled_patient_59,0,,N/A,N/A,,,,,,
587.png,medpix_patient_73,0,,N/A,N/A,,,,,,
586.png,medpix_patient_73,0,,N/A,N/A,,,,,,
585.png,medpix_patient_73,0,,N/A,N/A,,,,,,
584.png,medpix_patient_77,0,,N/A,N/A,,,,,,
583.png,medpix_patient_77,0,,N/A,N/A,,,,,,
580.png,medpix_patient_4,0,,N/A,N/A,,,,,,
579.png,medpix_patient_4,0,,N/A,N/A,,,,,,
578.png,medpix_patient_4,0,,N/A,N/A,,,,,,
577.png,medpix_patient_4,0,,N/A,N/A,,,,,,
576.png,medpix_patient_30,0,,N/A,N/A,,,,,,
575.png,medpix_patient_30,0,,N/A,N/A,,,,,,
57%0.jpg,crawled_patient_57,0,,N/A,N/A,,,,,,
56%1.jpg,crawled_patient_56,0,,N/A,N/A,,,,,,
56%0.jpg,crawled_patient_56,0,,N/A,N/A,,,,,,
54%3.jpg,crawled_patient_54,0,,N/A,N/A,,,,,,
54%2.jpg,crawled_patient_54,0,,N/A,N/A,,,,,,
54%1.jpg,crawled_patient_54,0,,N/A,N/A,,,,,,
54%0.jpg,crawled_patient_54,0,,N/A,N/A,,,,,,
53.jpg,crawled_patient_53,0,,N/A,N/A,,,,,,
52%1.jpg,crawled_patient_52,0,,N/A,N/A,,,,,,
52%0.jpg,crawled_patient_52,0,,N/A,N/A,,,,,,
51%3.jpg,crawled_patient_51,0,,N/A,N/A,,,,,,
51%2.jpg,crawled_patient_51,0,,N/A,N/A,,,,,,
51%1.jpg,crawled_patient_51,0,,N/A,N/A,,,,,,
51%0.jpg,crawled_patient_51,0,,N/A,N/A,,,,,,
50.jpg,crawled_patient_50,0,,N/A,N/A,,,,,,
5%7.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
5%6.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
5%5.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
5%4.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
5%3.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
5%2.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
5%1.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
5%0.jpg,crawled_patient_5,0,,N/A,N/A,,,,,,
49%1.jpg,crawled_patient_49,0,,N/A,N/A,,,,,,
49%0.jpg,crawled_patient_49,0,,N/A,N/A,,,,,,
487.png,medpix_patient_25,0,,N/A,N/A,,,,,,
486.png,medpix_patient_25,0,,N/A,N/A,,,,,,
48.jpg,crawled_patient_48,0,,N/A,N/A,,,,,,
47.jpg,crawled_patient_47,0,,N/A,N/A,,,,,,
46.jpg,crawled_patient_46,0,,N/A,N/A,,,,,,
452.png,medpix_patient_54,0,,N/A,N/A,,,,,,
45.jpg,crawled_patient_45,0,,N/A,N/A,,,,,,
44.png,medpix_patient_67,0,,N/A,N/A,,,,,,
44%1.jpg,crawled_patient_44,0,,N/A,N/A,,,,,,
44%0.jpg,crawled_patient_44,0,,N/A,N/A,,,,,,
43.png,medpix_patient_67,0,,N/A,N/A,,,,,,
43%3.jpg,crawled_patient_43,0,,N/A,N/A,,,,,,
43%2.jpg,crawled_patient_43,0,,N/A,N/A,,,,,,
43%1.jpg,crawled_patient_43,0,,N/A,N/A,,,,,,
42.jpg,crawled_patient_42,0,,N/A,N/A,,,,,,
414.png,medpix_patient_8,0,,N/A,N/A,,,,,,
413.png,medpix_patient_8,0,,N/A,N/A,,,,,,
412.png,medpix_patient_8,0,,N/A,N/A,,,,,,
41.jpg,crawled_patient_41,0,,N/A,N/A,,,,,,
40%1.jpg,crawled_patient_40,0,,N/A,N/A,,,,,,
40%0.jpg,crawled_patient_40,0,,N/A,N/A,,,,,,
4%7.jpg,crawled_patient_4,0,,N/A,N/A,,,,,,
4%5.jpg,crawled_patient_4,0,,N/A,N/A,,,,,,
4%3.jpg,crawled_patient_4,0,,N/A,N/A,,,,,,
4%1.jpg,crawled_patient_4,0,,N/A,N/A,,,,,,
39%8.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%7.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%6.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%5.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%4.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%3.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%2.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%1.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
39%0.jpg,crawled_patient_39,0,,N/A,N/A,,,,,,
385.png,medpix_patient_68,0,,N/A,N/A,,,,,,
383.png,medpix_patient_68,0,,N/A,N/A,,,,,,
382.png,medpix_patient_68,0,,N/A,N/A,,,,,,
381.png,medpix_patient_68,0,,N/A,N/A,,,,,,
38%2.jpg,crawled_patient_38,0,,N/A,N/A,,,,,,
38%1.jpg,crawled_patient_38,0,,N/A,N/A,,,,,,
38%0.jpg,crawled_patient_38,0,,N/A,N/A,,,,,,
378.png,medpix_patient_20,0,,N/A,N/A,,,,,,
37%4.jpg,crawled_patient_37,0,,N/A,N/A,,,,,,
37%3.jpg,crawled_patient_37,0,,N/A,N/A,,,,,,
37%2.jpg,crawled_patient_37,0,,N/A,N/A,,,,,,
37%1.jpg,crawled_patient_37,0,,N/A,N/A,,,,,,
37%0.jpg,crawled_patient_37,0,,N/A,N/A,,,,,,
361.png,medpix_patient_49,0,,N/A,N/A,,,,,,
36%1.jpg,crawled_patient_36,0,,N/A,N/A,,,,,,
36%0.jpg,crawled_patient_36,0,,N/A,N/A,,,,,,
354.png,medpix_patient_84,0,,N/A,N/A,,,,,,
35%2.jpg,crawled_patient_35,0,,N/A,N/A,,,,,,
35%1.jpg,crawled_patient_35,0,,N/A,N/A,,,,,,
35%0.jpg,crawled_patient_35,0,,N/A,N/A,,,,,,
34.jpg,crawled_patient_34,0,,N/A,N/A,,,,,,
33.png,medpix_patient_40,0,,N/A,N/A,,,,,,
33%1.jpg,crawled_patient_33,0,,N/A,N/A,,,,,,
33%0.jpg,crawled_patient_33,0,,N/A,N/A,,,,,,
32%1.jpg,crawled_patient_32,0,,N/A,N/A,,,,,,
32%0.jpg,crawled_patient_32,0,,N/A,N/A,,,,,,
31.jpg,crawled_patient_31,0,,N/A,N/A,,,,,,
30%5.jpg,crawled_patient_30,0,,N/A,N/A,,,,,,
30%4.jpg,crawled_patient_30,0,,N/A,N/A,,,,,,
30%3.jpg,crawled_patient_30,0,,N/A,N/A,,,,,,
30%2.jpg,crawled_patient_30,0,,N/A,N/A,,,,,,
30%1.jpg,crawled_patient_30,0,,N/A,N/A,,,,,,
30%0.jpg,crawled_patient_30,0,,N/A,N/A,,,,,,
3.jpg,crawled_patient_3,0,,N/A,N/A,,,,,,
294.png,medpix_patient_64,0,,N/A,N/A,,,,,,
29%3.jpg,crawled_patient_29,0,,N/A,N/A,,,,,,
29%2.jpg,crawled_patient_29,0,,N/A,N/A,,,,,,
29%1.jpg,crawled_patient_29,0,,N/A,N/A,,,,,,
29%0.jpg,crawled_patient_29,0,,N/A,N/A,,,,,,
28.jpg,crawled_patient_28,0,,N/A,N/A,,,,,,
27.jpg,crawled_patient_27,0,,N/A,N/A,,,,,,
26.png,medpix_patient_69,0,,N/A,N/A,,,,,,
26%3.jpg,crawled_patient_26,0,,N/A,N/A,,,,,,
26%2.jpg,crawled_patient_26,0,,N/A,N/A,,,,,,
26%1.jpg,crawled_patient_26,0,,N/A,N/A,,,,,,
26%0.jpg,crawled_patient_26,0,,N/A,N/A,,,,,,
25.png,medpix_patient_69,0,,N/A,N/A,,,,,,
25%3.jpg,crawled_patient_25,0,,N/A,N/A,,,,,,
25%2.jpg,crawled_patient_25,0,,N/A,N/A,,,,,,
25%1.jpg,crawled_patient_25,0,,N/A,N/A,,,,,,
25%0.jpg,crawled_patient_25,0,,N/A,N/A,,,,,,
24.png,medpix_patient_69,0,,N/A,N/A,,,,,,
2341.png,medpix_patient_9,0,,N/A,N/A,,,,,,
23.png,medpix_patient_69,0,,N/A,N/A,,,,,,
227.png,medpix_patient_36,0,,N/A,N/A,,,,,,
226.png,medpix_patient_36,0,,N/A,N/A,,,,,,
2237.png,medpix_patient_52,0,,N/A,N/A,,,,,,
22%1.jpg,crawled_patient_22,0,,N/A,N/A,,,,,,
22%0.jpg,crawled_patient_22,0,,N/A,N/A,,,,,,
2145.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2144.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2143.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2142.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2141.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2140.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2139.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2138.png,medpix_patient_32,0,,N/A,N/A,,,,,,
2108.png,medpix_patient_12,0,,N/A,N/A,,,,,,
21%1.jpg,crawled_patient_21,0,,N/A,N/A,,,,,,
21%0.jpg,crawled_patient_21,0,,N/A,N/A,,,,,,
2041.png,medpix_patient_56,0,,N/A,N/A,,,,,,
2040.png,medpix_patient_56,0,,N/A,N/A,,,,,,
2039.png,medpix_patient_56,0,,N/A,N/A,,,,,,
2007.png,medpix_patient_65,0,,N/A,N/A,,,,,,
20.jpg,crawled_patient_20,0,,N/A,N/A,,,,,,
2%3.jpg,crawled_patient_2,0,,N/A,N/A,,,,,,
2%2.jpg,crawled_patient_2,0,,N/A,N/A,,,,,,
2%1.jpg,crawled_patient_2,0,,N/A,N/A,,,,,,
2%0.jpg,crawled_patient_2,0,,N/A,N/A,,,,,,
1952.png,medpix_patient_71,0,,N/A,N/A,,,,,,
1924.png,medpix_patient_3,0,,N/A,N/A,,,,,,
1923.png,medpix_patient_3,0,,N/A,N/A,,,,,,
1922.png,medpix_patient_3,0,,N/A,N/A,,,,,,
1921.png,medpix_patient_3,0,,N/A,N/A,,,,,,
1920.png,medpix_patient_3,0,,N/A,N/A,,,,,,
1919.png,medpix_patient_33,0,,N/A,N/A,,,,,,
19%1.jpg,crawled_patient_19,0,,N/A,N/A,,,,,,
19%0.jpg,crawled_patient_19,0,,N/A,N/A,,,,,,
1889.png,medpix_patient_18,0,,N/A,N/A,,,,,,
1888.png,medpix_patient_18,0,,N/A,N/A,,,,,,
1877.png,medpix_patient_22,0,,N/A,N/A,,,,,,
1876.png,medpix_patient_22,0,,N/A,N/A,,,,,,
1868.png,medpix_patient_35,0,,N/A,N/A,,,,,,
1859.png,medpix_patient_0,0,,N/A,N/A,,,,,,
1858.png,medpix_patient_0,0,,N/A,N/A,,,,,,
1857.png,medpix_patient_0,0,,N/A,N/A,,,,,,
1846.png,medpix_patient_29,0,,N/A,N/A,,,,,,
1845.png,medpix_patient_29,0,,N/A,N/A,,,,,,
1814.png,medpix_patient_63,0,,N/A,N/A,,,,,,
18%3.jpg,crawled_patient_18,0,,N/A,N/A,,,,,,
18%2.jpg,crawled_patient_18,0,,N/A,N/A,,,,,,
18%1.jpg,crawled_patient_18,0,,N/A,N/A,,,,,,
18%0.jpg,crawled_patient_18,0,,N/A,N/A,,,,,,
177.png,medpix_patient_10,0,,N/A,N/A,,,,,,
176.png,medpix_patient_10,0,,N/A,N/A,,,,,,
174.png,medpix_patient_78,0,,N/A,N/A,,,,,,
171.png,medpix_patient_78,0,,N/A,N/A,,,,,,
1702.png,medpix_patient_16,0,,N/A,N/A,,,,,,
17%1.jpg,crawled_patient_17,0,,N/A,N/A,,,,,,
17%0.jpg,crawled_patient_17,0,,N/A,N/A,,,,,,
167.png,medpix_patient_60,0,,N/A,N/A,,,,,,
166.png,medpix_patient_60,0,,N/A,N/A,,,,,,
1638.png,medpix_patient_83,0,,N/A,N/A,,,,,,
16.jpg,crawled_patient_16,0,,N/A,N/A,,,,,,
158.png,medpix_patient_37,0,,N/A,N/A,,,,,,
1577.png,medpix_patient_59,0,,N/A,N/A,,,,,,
1576.png,medpix_patient_59,0,,N/A,N/A,,,,,,
1575.png,medpix_patient_59,0,,N/A,N/A,,,,,,
1562.png,medpix_patient_72,0,,N/A,N/A,,,,,,
1561.png,medpix_patient_72,0,,N/A,N/A,,,,,,
1501.png,medpix_patient_24,0,,N/A,N/A,,,,,,
1500.png,medpix_patient_24,0,,N/A,N/A,,,,,,
15.png,medpix_patient_38,0,,N/A,N/A,,,,,,
15%3.jpg,crawled_patient_15,0,,N/A,N/A,,,,,,
15%2.jpg,crawled_patient_15,0,,N/A,N/A,,,,,,
15%1.jpg,crawled_patient_15,0,,N/A,N/A,,,,,,
15%0.jpg,crawled_patient_15,0,,N/A,N/A,,,,,,
1499.png,medpix_patient_24,0,,N/A,N/A,,,,,,
1498.png,medpix_patient_24,0,,N/A,N/A,,,,,,
1497.png,medpix_patient_24,0,,N/A,N/A,,,,,,
1463.png,medpix_patient_48,0,,N/A,N/A,,,,,,
1428.png,medpix_patient_42,0,,N/A,N/A,,,,,,
14.png,medpix_patient_38,0,,N/A,N/A,,,,,,
14%3.jpg,crawled_patient_14,0,,N/A,N/A,,,,,,
14%2.jpg,crawled_patient_14,0,,N/A,N/A,,,,,,
14%1.jpg,crawled_patient_14,0,,N/A,N/A,,,,,,
14%0.jpg,crawled_patient_14,0,,N/A,N/A,,,,,,
1336.png,medpix_patient_51,0,,N/A,N/A,,,,,,
1335.png,medpix_patient_51,0,,N/A,N/A,,,,,,
1333.png,medpix_patient_39,0,,N/A,N/A,,,,,,
1332.png,medpix_patient_39,0,,N/A,N/A,,,,,,
1331.png,medpix_patient_39,0,,N/A,N/A,,,,,,
1330.png,medpix_patient_39,0,,N/A,N/A,,,,,,
1328.png,medpix_patient_39,0,,N/A,N/A,,,,,,
1313.png,medpix_patient_26,0,,N/A,N/A,,,,,,
1312.png,medpix_patient_26,0,,N/A,N/A,,,,,,
1310.png,medpix_patient_15,0,,N/A,N/A,,,,,,
1309.png,medpix_patient_15,0,,N/A,N/A,,,,,,
1308.png,medpix_patient_15,0,,N/A,N/A,,,,,,
1307.png,medpix_patient_15,0,,N/A,N/A,,,,,,
1306.png,medpix_patient_15,0,,N/A,N/A,,,,,,
1305.png,medpix_patient_15,0,,N/A,N/A,,,,,,
13.jpg,crawled_patient_13,0,,N/A,N/A,,,,,,
1298.png,medpix_patient_7,0,,N/A,N/A,,,,,,
1297.png,medpix_patient_7,0,,N/A,N/A,,,,,,
1277.png,medpix_patient_58,0,,N/A,N/A,,,,,,
1264.png,medpix_patient_6,0,,N/A,N/A,,,,,,
1263.png,medpix_patient_6,0,,N/A,N/A,,,,,,
1262.png,medpix_patient_6,0,,N/A,N/A,,,,,,
1261.png,medpix_patient_6,0,,N/A,N/A,,,,,,
1240.png,medpix_patient_23,0,,N/A,N/A,,,,,,
1239.png,medpix_patient_23,0,,N/A,N/A,,,,,,
1238.png,medpix_patient_46,0,,N/A,N/A,,,,,,
1221.png,medpix_patient_41,0,,N/A,N/A,,,,,,
1218.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1217.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1216.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1215.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1214.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1213.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1212.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1211.png,medpix_patient_2,0,,N/A,N/A,,,,,,
1210.png,medpix_patient_2,0,,N/A,N/A,,,,,,
120.png,medpix_patient_34,0,,N/A,N/A,,,,,,
12.jpg,crawled_patient_12,0,,N/A,N/A,,,,,,
118.png,medpix_patient_82,0,,N/A,N/A,,,,,,
117.png,medpix_patient_82,0,,N/A,N/A,,,,,,
1164.png,medpix_patient_79,0,,N/A,N/A,,,,,,
116.png,medpix_patient_82,0,,N/A,N/A,,,,,,
115.png,medpix_patient_82,0,,N/A,N/A,,,,,,
114.png,medpix_patient_82,0,,N/A,N/A,,,,,,
1124.png,medpix_patient_76,0,,N/A,N/A,,,,,,
1123.png,medpix_patient_76,0,,N/A,N/A,,,,,,
112.png,medpix_patient_74,0,,N/A,N/A,,,,,,
1115.png,medpix_patient_70,0,,N/A,N/A,,,,,,
1101.png,medpix_patient_17,0,,N/A,N/A,,,,,,
1100.png,medpix_patient_17,0,,N/A,N/A,,,,,,
11%2.jpg,crawled_patient_11,0,,N/A,N/A,,,,,,
11%1.jpg,crawled_patient_11,0,,N/A,N/A,,,,,,
11%0.jpg,crawled_patient_11,0,,N/A,N/A,,,,,,
1099.png,medpix_patient_17,0,,N/A,N/A,,,,,,
1098.png,medpix_patient_53,0,,N/A,N/A,,,,,,
1094.png,medpix_patient_45,0,,N/A,N/A,,,,,,
1093.png,medpix_patient_45,0,,N/A,N/A,,,,,,
1079.png,medpix_patient_75,0,,N/A,N/A,,,,,,
1078.png,medpix_patient_75,0,,N/A,N/A,,,,,,
1072.png,medpix_patient_1,0,,N/A,N/A,,,,,,
1071.png,medpix_patient_1,0,,N/A,N/A,,,,,,
1070.png,medpix_patient_1,0,,N/A,N/A,,,,,,
1065.png,medpix_patient_80,0,,N/A,N/A,,,,,,
1062.png,medpix_patient_31,0,,N/A,N/A,,,,,,
1061.png,medpix_patient_31,0,,N/A,N/A,,,,,,
1060.png,medpix_patient_31,0,,N/A,N/A,,,,,,
1059.png,medpix_patient_31,0,,N/A,N/A,,,,,,
1058.png,medpix_patient_31,0,,N/A,N/A,,,,,,
1050.png,medpix_patient_13,0,,N/A,N/A,,,,,,
1049.png,medpix_patient_13,0,,N/A,N/A,,,,,,
1048.png,medpix_patient_13,0,,N/A,N/A,,,,,,
1047.png,medpix_patient_13,0,,N/A,N/A,,,,,,
1046.png,medpix_patient_13,0,,N/A,N/A,,,,,,
104.png,medpix_patient_62,0,,N/A,N/A,,,,,,
1030.png,medpix_patient_55,0,,N/A,N/A,,,,,,
103.png,medpix_patient_62,0,,N/A,N/A,,,,,,
1029.png,medpix_patient_55,0,,N/A,N/A,,,,,,
102.png,medpix_patient_62,0,,N/A,N/A,,,,,,
10%2.jpg,crawled_patient_10,0,,N/A,N/A,,,,,,
10%1.jpg,crawled_patient_10,0,,N/A,N/A,,,,,,
10%0.jpg,crawled_patient_10,0,,N/A,N/A,,,,,,
1%2.jpg,crawled_patient_1,0,,N/A,N/A,,,,,,
1%1.jpg,crawled_patient_1,0,,N/A,N/A,,,,,,
1%0.jpg,crawled_patient_1,0,,N/A,N/A,,,,,,
0.jpg,crawled_patient_0,0,,N/A,N/A,,,,,,"NTM, nontuberculous mycobacterium. "
